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ABSTRACT 
The post-translational addition of a single O-linked β-N-acetylglucosamine (O-
GlcNAc) to serine or threonine residues is an important element in an ever-
increasing array of metazoan cellular and regulatory processes. The enzyme 
responsible for this modification, O-GlcNAc transferase (OGT), is conserved 
among a wide variety of organisms and is critical for viability in many eukaryotes, 
including humans, mice, and Drosophila. Although OGTs with domain structure 
similar to eukaryotic OGTs are predicted for numerous bacteria species, their 
cellular roles remain unknown. I have identified an OGT in the cyanobacterium 
Synechococcus elongatus PCC 7942 that has active site homology and similar 
domain structure to eukaryotic OGTs. An OGT deletion mutant was created 
(∆ogt), which is viable and has no defect in growth rate, but has several 
phenotypes of interest. Without agitation, ∆ogt cells aggregate, and settle out of 
media. Compared to wild type cells, the ∆ogt cells also have higher free cellular 
phosphate levels, wider thylakoid lumen, and differential organization of electron 
dense inclusion bodies. These phenotypes are rescued by re-introduction of the 
wild type OGT, but are not fully rescued by OGTs with single amino acid 
substitutions corresponding to mutations that reduce eukaryotic OGT activity.  
S. elongatus OGT purified from E. coli hydrolyzes the donor sugar, UDP-GlcNAc, 
while mutant OGTs that do not fully rescue the deletion mutant have reduced or 
no activity. These results suggest that the eukaryotic-like OGTs of bacteria affect 
multiple processes. 
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Although the substrates for the SeOGT remain elusive, I have uncovered 
a relationship between the SeOGT and pili through a mutation that suppresses 
the ∆ogt settling phenotype. A single amino acid substitution (alanine 107 to 
aspartic acid) in the protein PilA suppresses two mutant phenotypes, settling and 
loss of pili. PilA is a subunit of type four pili (fimbriae), which are frequently found 
on the surfaces of gram-negative bacteria. Fimbriae are involved in virulence, 
DNA uptake, twitching motility, and adhesion. Although pilus assembly is a 
complex process, pili are primarily homopolymers of PilA, which is added or 
subtracted via ATPases to either extend or retract the pilus. No pili are detectable 
in ∆ogt cells, while pili are restored to ∆ogt cells by the pilA(A107D) mutation. When 
present together, mutant and wild type pilA genes prevent the assembly of pili, 
suggesting that there is a toxic interaction between mutant and wild type proteins 
which results in inability to assemble pili. This occurs regardless of the presence 
of OGT.  Glycosylation of extra-cellular appendages have been widely reported. 
Pili are known substrates of glycosylation and glycosylation states have been 
reported to be important in the function of pili. The suppression of ∆ogt 
phenotypes by mutant PilA suggests that PilA is either a substrate of the OGT or 
that another protein involved in pilus synthesis is modified by OGT.  
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Chapter One 
Introduction 
Post-translational modification is the most common mechanism to regulate 
protein function and quality control. Many of these modifications such as 
phosphorylation, acetylation, and myristoylation have been studied for decades. 
A more recently discovered modification type, O-GlcNAcylation, involves the 
covalent attachment of a single β-N-acetylglucosamine to the hydroxyl group of a 
serine or threonine residue. The enzyme responsible for this modification is O-
linked β-N-acetylglucosamine transferase (EC 2.4.1.255), also known as O-
GlcNAc transferase (OGT). This modification has unique properties amongst 
most other glycosylations, in that it occurs in the nucleus and cytosol (as 
opposed to the secretory endomembrane system), and, similar to 
phosphorylation, is labile. The ever-growing number of cellular systems this 
modification is involved in has led to a quickly expanding body of research to 
further understand the mechanisms and roles of O-GlcNAcylation. 
 
The O-GlcNAc modification 
 First discovered in 1984 by Torres and Hart on the surface of lymphocytes 
(1), it quickly became apparent that this modification is a critical component of  
many biological processes such as glucose signaling, transcription, and cell cycle 
progression. Formation of the O-GlcNAc modification consists of the transfer of a 
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single GlcNAc sugar from the UDP-GlcNAc donor to the hydroxyl of a serine or 
threonine residue, creating an O-linked GlcNAc (Fig. 1). Over 4000 proteins are 
currently known to be modified by O-GlcNAc, and new substrate proteins 
continue to be reported frequently (2). Diverse types of proteins carry the O-
GlcNAc modification, including transcription factors, cytoskeletal proteins, 
hormone receptors, and chromatin-associated proteins. The OGT enzyme is 
found throughout many metazoan species, including Drosophila, C. elegans, 
mice, and humans (3). 
 O-GlcNAcylation has unique characteristics among post-translational 
modifications and glycosylation alike. Until recent decades, posttranslational 
modification (PTM) was thought to occur in the endoplasmic reticulum and Golgi 
apparatus, with glycosylated and proteins trafficked directly to their final location, 
such as membranes, vesicles, and the cell exterior. Cytoplasmic and nuclear 
proteins were not believed be glycosylated. O-GlcNAcylation broke both of these 
precepts. Not only is this post-translational modification made in the nucleus and 
cytosol, the newly modified proteins are found to function throughout 
nucleocytosolic regions (4). Many post-translational modifications such as 
prenylation or N-linked glycosylation are stable. For O-GlcNAcylation, however, 
this is not the case. O-GlcNAcylation, like phosphorylation, can occur in a 
dynamic manner through addition and removal of the glycan (4).  
 Unfortunately, this modification has several characteristics that make the 
investigation of its cellular roles difficult. Unlike many other PTMs, there is no 
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well-defined consensus sequence allowing the prediction of the location of O-
GlcNAcylation. Because of the reversible nature of the modification, target 
substrates can be difficult to identify due to low levels of modification. Among the 
most vexing problems is the essentiality of the enzyme to most organisms. In 
mice and Drosophila, null mutants result in lethality (5, 6). C. elegans and 
zebrafish can survive without O-GlcNAcylation  (7, 8). Currently the simplest 
model organism in which to study the modification is the multicellular early 
metazoan Trichoplax adhaerens (9), as yeast and E. coli do not have OGT 
homologs. 
 
Cellular roles of O-GlcNAc modification 
O-GlcNAcylation was first characterized on the exterior of lymphocyte cells, but 
soon was discovered to be a very abundant modification on rat liver organelles, 
particularly the nuclear envelope (1). Human erythrocytes were next to be 
reported to contain O-GlcNAcylated proteins, including cytoskeletal proteins that 
interact with actin (10, 11). Just a few years later, the polytene chromosomes of 
salivary glands in Drosophila were reported to be heavily decorated with O-
GlcNAcylated proteins (12). O-GlcNAcylation was later studied in C. elegans, 
Arabidopsis thaliana, zebrafish, and other model organisms (7, 8, 13). 
Thousands of metazoan substrate proteins with the O-GlcNAc modification have 
been reported to date, reflecting the myriad roles of this modification (14, 15).  
Some of the most well-studied cellular roles affected by O-GlcNAcylation include 
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nutrient sensing in diabetes (16), cell cycle signaling in cancer (17), and the brain 
protein tau in neurodegenerative diseases (18). 
 
Phosphorylation crosstalk 
 O-GlcNAcylation can act in competition with phosphorylation of the same 
sites or proximal sites, with one modification precluding the other. The crosstalk 
between O-GlcNAc and phosphorylation states implicates the O-GlcNAc 
modification’s role in more complex cell signaling, via not simply the presence or 
absence of the O-GlcNAc moiety, but the interference or enhancement of 
phosphorylation signaling. Notably, unlike phosphorylation signaling, which 
employs a plethora of site-specific kinases, the cycling of O-GlcNAcylation relies 
on few highly conserved enzymes. O-GlcNAcylation commonly has only one 
enzyme for addition, O-GlcNAc transferase (OGT), and one enzyme for removal, 
O-GlcNAc hydrolase (OGA).  In most species, a single, highly conserved gene 
coding for O-GlcNAc transferase, is present coding for the enzyme responsible 
for this modification, although some organisms have two OGTs (3). Congruently, 
a single gene, O-GlcNAc hydrolase (OGA), encodes the enzyme that allows for 
the dynamic nature of the modification by removing the sugar.  
 
Enzyme structure and function 
O-GlcNAcylation is effected by the enzyme O-linked β-N-acetylglucosamine 
transferase (EC 2.4.1.255), also known as O-GlcNAc transferase (OGT). In 
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general, O-GlcNAc transferases consist of a variable number of N-terminal 
tetratricopeptide repeats and two C-terminal catalytic domains with an 
intervening domain between the catalytic domains. The dual catalytic domains 
classify the enzyme as a GT41 GT-B glycosyltransferase (CAZY 
http://www.cazy.org/GT41.html). The TPR domain has been structurally 
characterized through x-ray crystallography, which shows that it folds into the 
predicted superhelical fold with a long groove (19). Although numerous known 
mutations identified critical amino acids and predicted a possible active site 
location (20), the true structure of an OGT remained elusive until 2008, when two 
separate groups published the first crystal structure of an OGT (21, 22). These 
publications both reported on the structure of an OGT homolog from the bacteria 
Xanthomonas campestris (XcOGT). Due to the hydrolytic activity of the enzyme 
against the sugar donor uridine diphosphate N-acetylglucosamine (UDP-
GlcNAc), it was only possible to crystalize the OGT with either UDP or a UDP-
GlcNAc analog to show enzyme-GlcNAc interaction. Finally, the elusive human 
OGT crystal structure was reported by Lazarus et al. (23) and it displayed 
significant structural homology to the XcOGT. Human OGT (HsOGT) was co-
crystallized with UDP and, separately (but for the first time), with a peptide 
substrate. Most recently, Schimpl et al. (24) co-crystallized HsOGT with both a 
UDP and a UDP-GlcNAc analogue and several peptide substrates (see Table 1 
for summary of crystalized OGT and substrates). 
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All of these crystal structures are essentially identical, having an active 
site with a deep binding pocket for the sugar donor, and a long crevice for the 
protein substrate. The two active sites fit tightly together with the TPR domain, 
with the superhelical groove of the TPRs extending into the active site formed by 
the two catalytic domains. These initial structures suggest a model wherein the 
UDP-GlcNAc binds deeply in the active site pocket, followed by a substrate 
protein that is guided via interactions with the TPRs into proximity with the sugar 
donor, thereby allowing modification to occur.  
The association of the TPRs with protein substrates, suggested by the 
bacterial crystal structure, are supported by mutational analyses of HsOGT (25) . 
In humans, three splice isoforms of OGT with different TPR domain lengths are 
present, each showing differential substrate specificity, which also supports this 
model (26). A partial TPR may also provide a secure lid to the active site when 
UDP-GlcNAc is bound, conformationally changing to close the access to the 
active site and trap the donor (22). Mutations in this active site lid support this 
role, including the Arabidopsis OGT mutations spy-12 (27) and the SeOGT 
mutant discussed in this work, G350D (Chapter Two) (28).  
 The initial structures proposed several key residues, including two 
histidines near the active site, and a lysine deep in the active site. The authors 
proposed the lysine K842 interacts with the sugar donor, which is also supported 
by mutational studies (22). The histidines H498 and H558 were both proposed to 
be the key catalytic residues for transfer of the sugar to the protein (21). These 
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residues have been shown via mutational studies to be important for OGT 
function. In 2012, the HsOGT was co-crystallized with native UDP-GlcNAc (not 
an analog) and several different peptides (24). These structures demonstrate that 
the H498 is too far from the acceptor hydroxyl to act as a catalytic base. H558, 
although critical for enzyme function, is proposed to be structurally inhibited from 
acting as the catalytic base (24). The authors also report an unusual “back-bent” 
formation of the sugar donor, and suggest that the alpha-phosphate on the donor 
substrate itself serves as the catalytic base. 
 
Bacterial glycosylation 
Although long believed to be solely a eukaryotic attribute, several 
glycosylation pathways are now evident in prokaryotes as well. Glycans added to 
serine or threonine residues via O-linkages have a wide array of structures. 
Similarly, glycans added to asparagine residues via N-linkages also share 
numerous synthetic pathways and structures. These pathways are currently 
being harnessed in the field of bacterial glycoengineering to create novel 
therapeutics, and show promise in diverse applications, including antibody 
variants for recruiting immune cells to target cancer and glycosylation of proteins 
to improve pharmacokinetic properties such as half-life and in vivo activity.  
Although bacterial glycoproteins are a relatively new discovery, it has 
become apparent that prokaryotic glycosylation plays an important role. The first 
glycoproteins found in bacteria were found on the S-layer of the archeon 
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Halobacterium salinarum, as well as the S-layers of two Clostridium species (29). 
Since then it has been established that both O-linked and N-linked glycoproteins 
are ubiquitous and play important roles in the prokaryotic world. They have been 
implicated in functional roles from pathogenicity, antigenicity, enzymatic activity, 
and cell surface protein adhesion (see (30), and (31) for review). Eukaryotes use 
five different linkage types to decorate glycoproteins, N-linked glycans on 
asparagine or arginine, O-linked glycans on serine, threonine, hydroxyproline, 
and hydroxylysine, phosphate linked glycans on serine, C-linked glycans on 
tryptophan, and glypiation, which uses a glycosylphosphatidylinositol anchor and 
a phosphoethanolamine linker to glycosylate C-terminal ends of proteins. 
Bacteria use mostly N- and O-linkages, but have additional rare modifications, S-
linked modification of cysteine and O-linked modification of tyrosine (31). 
Bacterial glycoproteins can be synthesized sequentially, with each additional 
sugar added to an existing N- or O-linked chain, or en bloc. The types of sugars 
included in bacterial glycosylation include glucose, galactose, mannose, fucose, 
rhamnose, arabinose, GalNAc (N-acetylgalactosamine) and GlcNAc (N-
acetylglucosamine) as well as some sugars novel to bacteria, such as 2,4-
diacetimido-2,4,6-trideoxyhexose. 
N-linked bacterial glycosylation has been well documented in 
Campylobacter jejuni (31). The pathway starts with a lipid-linked oligosaccharide, 
which is synthesized in the cytoplasm and then translocated to the periplasm via 
a flippase. Protein glycosylation genes (pgl) are responsible for the glycoslylation 
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of flagella. Flagella are helical filaments on the cell surface that are involved in 
locomotion and virulence and mutations in the genes responsible for this action 
inhibit virulence, by affecting adherence, invasion, and colonization (32). Other 
glycosylation targets are surface proteins and periplasmic proteins. 
The study of O-linked glycosylation in the structure and function of flagella 
and other cell surface proteins has been particularly well studied. In Gram-
negative bacteria, a well-documented substrate for glycosylation is the flagellum. 
Among different species, glycosylation of flagellins varies in number between 
species from a single glycosylation site in Listeria monocytogenes (33), to up to 
19 sites in Burkholderia spp. (34). Heterogeneity of types of flagellin glycosylation 
is wide, even among closely related species (see (35) for review), which may be 
useful in evolving surface recognition and thereby virulence against hosts. In 
Listeria monocytogenes, flagella are proposed to be modified with O-GlcNAc at 
multiple sites, although the function of this glycosylation remains unclear (33, 36). 
Bacterial cell surfaces contain other glycoproteins as well, playing roles in 
adhesion, secretion, signaling, and virulence, among others (see (30) for review).  
 
O-GlcNAc Transferase in the prokaryotic world 
Reports of O-GlcNAc transferase-mediated glycosylation in bacteria have 
been relatively rare, with no known functional roles to this point. In 2004, Listeria 
monocytogenes flagellins were investigated by mass spectrometry and reported 
to contain several O-linked HexNAc modifications (33). Immunostaining with the 
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CTD110.1 antibody supported the hypothesis that the flagellins were O-
GlcNAcylated, however, the antibody has been reported to react non-specifically 
(37). The enzyme responsible for this modification however, remains unknown, 
as do the functional roles for the modification. Another flagellin-associated 
modification was reported to regulate flagellar motility in Listeria (36). This 
reported enzyme, GmaR interacts with a DNA-binding protein to regulate motility 
and is reported to modify the flagellin with O-GlcNAc. Intriguingly, GmaR shows 
no sequence homology to any other known O-GlcNAc transferase. This is 
striking, as all metazoan OGTs show some domain structure and/or active site 
sequence homology, suggesting that prokaryotes may have multiple pathways 
for the creation of the O-GlcNAc modification. 
There are several suggested bacterial OGTs that are more similar to 
eukaryotic OGTs. The most studied is the OGT of Xanthomonas campestris, 
which has been crystallized and has remarkable similarity to the human OGT 
crystal structure. This enzyme has been reported to be an active OGT, although 
its cellular roles remain unknown (21). A cell surface protein in the cyanobacteria 
Microcystis aeruginosa, MrpC, which is involved with cell-to-cell contact, has 
been reported to be O-GlcNAcylated (38). These findings are based on the mass 
detected by mass spectrometry, however, the precursor ion is reported to be 
160Da, whereas the O-GlcNAc moiety is 206Da. Interestingly, the mrpC gene 
lies in a cluster with two proposed glycosyltransferases, SlpA and SlpB. Both of 
these proteins share some sequence homology with eukaryotic OGTs, however, 
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they differ in their domain organization, with TPRs distributed throughout the 
proteins, not solely at the N-terminal. The O-GlcNAc modification is reported to 
be important for cell surface retention, however, the effects of blocking this 
modification are unknown, as is the specific role of the modification. 
Due to the difficulty of studying O-GlcNAcylation in eukaryotes, a bacterial 
model would contribute a novel system for the further research into the cellular 
roles of O-GlcNAcylation. The photosynthetic cyanobacterium Synechococcus 
elongatus PCC7942 is predicted to have one O-GlcNAc transferase gene, with 
characteristic eukaryotic-like predicted protein structure. Sokol and Olszewski 
(28) propose that this is an active OGT similar to eukaryotic OGTs. (see Chapter 
Two) Phenotypes of null or mutant eukaryote-like OGTs have not yet been 
reported in prokaryotes and the biological roles of O-GlcNAcylated proteins in 
bacteria have not been investigated. The varied metabolic and regulatory 
pathways involving the O-GlcNAc modification in higher organisms suggest that 
this modification may be a regulatory element in prokaryotic systems as well.  
 
Aims of this study 
 Because of the important roles that O-GlcNAcylation play in metazoans 
and the discovery of O-linked glycans in bacteria, this study aims to investigate 
the O-GlcNAc modification of bacterial proteins. The metazoan O-GlcNAc 
transferase (OGT) is responsible for the O-GlcNAc modification and bacteria 
share a homolog of the OGT gene, suggesting that O-GlcNAcylation occurs in 
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prokaryotes as well. This work seeks to examine the cellular roles of bacterial 
OGT by examining the phenotypes and activity of mutant OGT strains in the 
bacterium Synechococcus elongatus PCC7942. Additionally, I investigate the 
relationship between OGT and the pili structural protein PilA and the 
glycosylation of pili. 
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Fig 1. The O-GlcNAc reaction.
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Table 1. Table of crystal and co-crystal structures 
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Year Group Species UDP UDP-GlcNAc 
*analogue 
Peptide Reference 
2008 van Aalten Xc  *X  (22) 
2008 Davies Xc X   (21) 
2011 Hanover Hs X  X (23) 
2012 Hanover Hs  *X X (39) 
2012 van Aalten Hs X *X X (24) 
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Chapter Two has been modified from the previously published work “The putative 
eukaryotic-like O-GlcNAc transferase of the cyanobacterium Synechococcus 
elongatus PCC7942 hydrolyzes UDP-GlcNAc and is involved in multiple cellular 
processes.” Sokol, KA, Olszewski, NE. 2015. Journal of Bacteriology, volume 
197, issue 2, pages 354-361. 
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Chapter Two 
The putative eukaryotic-like O-GlcNAc transferase of the cyanobacterium 
Synechococcus elongatus PCC7942 hydrolyzes UDP-GlcNAc and is 
involved in multiple cellular processes 
 
 
INTRODUCTION 
Although long believed to be solely a eukaryotic attribute, many glycosylation 
pathways are now evident in prokaryotes, as bacterial proteins can be modified 
with a variety of N-linked (40) and N-linked and O-linked glycans (35). Post-
translational modification of serine or threonine residues with single O-linked β-N-
acetylglucosamine (GlcNAc) by O-GlcNAc transferases (OGTs) is common in 
eukaryotes. All eukaryotic OGTs share a common domain structure consisting of 
tetratricopeptide repeats (TPRs) that are involved in protein-protein interactions  
(41) followed by the glycosyltransferase catalytic region (Fig. 1A). The catalytic 
region is composed of two highly conserved domains (3), which are linked by a 
variable length insertion. OGT homologs occur across prokaryotic phyla (3) and a 
number of these OGTs are “eukaryote-like” (Fig. 1B); this is best illustrated by 
the similarities in the crystal structures of the Xanthomonas campestris (21, 22) 
and the human OGTs (23, 24). In addition to sharing similar domain structures, 
key amino acids in and around the active site are conserved in the eukaryotic 
and bacterial enzymes (Fig. 2).  
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 Unlike other eukaryotic glycosylations, O-GlcNAcylation occurs in the 
nucleus and cytosol and is dynamically added and removed from proteins. O-
GlcNAcylation can regulate cellular processes directly or by acting in competition 
with phosphorylation (42, 43). Notably and unlike phosphorylation, which 
employs a plethora of site-specific kinases and phosphatases, the cycling of O-
GlcNAcylation relies on two, highly conserved enzymes that add and remove the 
sugar. An O-GlcNAc hydrolase capable of removing O-GlcNAc modifications 
from proteins has also been identified in bacteria (44), suggesting that the O-
GlcNAc modification may be present and dynamic in prokaryotes. Phenotypes of 
null or mutant eukaryote-like OGTs have not been reported in prokaryotes and 
the biological roles of O-GlcNAcylation in bacteria have not been investigated. 
 Diverse types of eukaryotic proteins, including transcription factors, 
cytoskeletal proteins, metabolic enzymes, hormone receptors, and chromatin are 
O-GlcNAc modified. The number and range of physiological systems affected by 
O-GlcNAcylation states are continuously growing (45). Although OGTs were 
identified over two decades ago, the regulation of glycan transfer and how this 
modification regulates cellular processes are not yet fully understood. Perhaps 
studying the OGT of a less complex organism will facilitate gaining insights into 
how it regulates cellular processes.  
 The photosynthetic cyanobacteria Synechococcus elongatus PCC7942 
has one predicted O-GlcNAc transferase (SeOGT), with a characteristic 
eukaryotic-like structure. We describe multiple mutant phenotypes of an OGT 
 20 
deletion strain. We also show homology with eukaryotic OGTs by demonstrating 
that SeOGT with mutations affecting amino acids important in eukaryotic OGTs 
do not fully rescue mutant phenotypes. Additionally, we demonstrate a decrease 
in hydrolysis of UDP-GlcNAc by the mutant SeOGTs. 
 
RESULTS 
S. elongatus has a eukaryotic-like OGT.  
A Blast search using the catalytic region of the Arabidopsis OGT SPY identified a 
putative S. elongatus OGT gene. The SeOGT gene (Synpcc7942_0051) is 
predicted to encode a 633 amino acid protein (ABB56083) with a eukaryotic-like 
domain structure of six predicted N-terminal tetratricopeptide repeats followed by 
the C-terminal catalytic region (Fig. 1B). Protein alignment using standard 
parameters of Emboss 6.3.1: matcher (http://mobyle.pasteur.fr) shows that 
SeOGT has 52% similarity to the Arabidopsis OGT SPY and 49% similarity to 
human OGT (HsOGT). The active site domain shows 59% similarity to SPY and 
49% similarity to HsOGT (Fig. 2). The full protein shows 45% similarity to the 
previously identified bacterial eukaryotic-like OGT from Xanthomonas campestris 
pv campestris .  
Phenotypes of an SeOGT deletion mutant.  
We created a SeOGT deletion strain (∆ogt) by replacing the coding region with 
an antibiotic marker cassette. The ∆ogt mutant displayed no obvious growth 
defect under standard growth conditions. However, without agitation from 
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shaking or aeration, the mutant cells showed a very distinct phenotype of settling 
to the bottom of the culture container (Fig. 3A). When the optical density (OD730) 
at a fixed height above the bottom of cuvettes was monitored, mutant cultures 
settled but wild type did not (Fig. 3B). The initial density of cultures affected the 
time to completion of settling, which varied from 24 hours for mid-exponential 
phase cultures, to a week for stationary cultures. Some settling occurred when 
wild type cultures were at high cell densities, possibly due to cell death or 
aggregation, whereas cultures at lower cell densities showed an initial increase in 
OD730, due to culture growth.  
To determine if mutant cells were viable post-settling, cultures were 
agitated and OD730 was measured (Fig. 3B). Both wild type and mutant cultures 
had similar densities at all time points indicating the mutant cells were viable and 
had the same growth rate as wild type. Further supporting this, the numbers of 
colony-forming units were similar after seven days of settling (Table 3). The 
buoyant densities of mutant and wild type cells were similar when assessed by 
isopycnic centrifugation on a Percoll gradient (Fig. 4), suggesting that a 
difference in buoyancy is not the cause of mutant cell settling. To determine if 
impaired metabolic function was involved in the settling phenotype, cells were 
treated with sodium azide, a biocide that acts by inhibiting electron transport, 
depleting the cells of ATP. Treatment accelerated the settling of mutant and wild 
type cells, and both settled at similar rates, which were greater than untreated 
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∆ogt cells (Fig. 5). Therefore metabolism contributes to the ability of both mutant 
and wild type to remain in suspension. 
 Upon inspection under standard light microscopy, mutant cells had no 
obvious morphological phenotypes. However, when cells were observed on 
hemocytometer slides, a higher fraction of the mutant cells were aggregated 
(Figs. 3C and 3D). To assess possible changes in cell wall or glycocalyx that 
might lead to increased cell aggregation, cells were examined by TEM. The 
mutant cells exhibited no obvious defects in cell wall structure or thickness (Fig. 
6A) but the thylakoid lumen of mutant cells was swollen (Figs. 6A, 6B). In 
addition, mutant cells had differential accumulation of electron-dense bodies 
between the thylakoid membranes (Fig. 7A), with more frequent, larger bodies 
deposited in mutant cells compared to wild type.  
Because polyphosphate bodies (PPBs) are electron-dense, we 
determined the amounts of inorganic phosphate bound in PPBs by using the 
exopolyphosphatase ScPPX1 to hydrolyze polyphosphate and measuring the 
resultant increase in inorganic phosphate (46). For both wild type and mutant 
cells, relatively small amounts of phosphate were released from polyphosphate, 
and there was no statistically significant difference in the amounts released (Fig. 
7B). Surprisingly, free cellular phosphate was nearly three-fold higher in mutant 
cells (Fig. 7B).   
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Transgene rescue of ∆ogt with wild type and mutant SeOGTs.  
To determine if the observed phenotypes were attributable to deleting the 
SeOGT gene, we reintroduced the wild type SeOGT coding region under the 
control of its predicted promoter into the ∆ogt strain via homologous 
recombination. The resulting strain was fully rescued for the settling (Fig. 8A) and 
cell aggregation phenotypes (Fig. 3D), while the thylakoid width defect was 
partially rescued (Fig. 6B). 
 A previously described G570D mutation in Arabidopsis, spy12, results in 
plants with altered hormone responses (47). The G570 residue is conserved in 
many phyla (Fig. 2), corresponding to G631 and G350 in the human and S. 
elongatus enzymes, respectively. A mutant SeOGT carrying a G350D mutation 
did not rescue the settling phenotype of the ∆ogt strain (Fig. 8A).  
Co-crystal structures for the HsOGT and the bacterial X. campestris OGT 
with various UDP-GlcNAc analogs and substrate peptides have recently been 
determined (22–24, 39). Based on these structures, several catalytically 
important residues have been proposed. Two histidines, HsOGT H558 and 
H498, have been predicted to be important in the transfer of GlcNAc to 
substrates (21–23). Additionally, a lysine residue, HsOGT K842, was shown to 
interact with the UDP portion of the sugar donor (22). Mutational studies have 
shown that each of these residues is critical for full enzymatic activity (21, 22, 
24). 
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 Although H498 is not conserved, H558 and K842 are conserved and 
correspond to H280 and K445 in SeOGT. Introduction of mutant SeOGT genes 
carrying the H280A and K445A mutations into ∆ogt did not rescue the settling 
phenotype (Fig. 8A), suggesting that, similar to human OGT, these residues also 
play an important role in SeOGT activity. 
SeOGT hydrolyzes UDP-GlcNAc.  
To determine if SeOGT has enzymatic activity, we took advantage of the ability 
of some sugar transferases to hydrolyze the bond between UDP and the sugar 
moiety (23).  Wild type SeOGT protein, and each of the three mutant SeOGTs 
were expressed in E. coli as MBP fusions and purified. Wild type SeOGT enzyme 
hydrolyzed more UDP-GlcNAc sugar than either the G350D or K445A enzymes 
(Fig. 8B). The G350D enzyme was more active than the negative controls (GFP-
MBP fusion protein and heat-killed OGT enzyme), suggesting it has some 
residual activity, but the activity of the K445A enzyme was not different from the 
negative controls. The H280A enzyme hydrolyzed slightly less UDP-GlcNAc, but 
was not significantly different from wild type. 
Non-informative experiments, over-expression and detection of substrates. 
Several methods are currently used to identify O-GlcNAcylated proteins including 
transfer of labeled galactose to a known terminal O-GlcNAc, antibodies against 
the O-GlcNAc modification, and chemi-enzymatic methods (48). The GalT assay 
uses the enzyme β-1,4-galactosyl transferase, which adds a radioactively labeled 
galactose to proteins with glycosylations terminating in GlcNAc. The BEMAB 
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method involves the elimination of the β-O-linkage between glycosylated serines 
or threonines, and substitution at this site with biotin, which labels any O-linkage. 
Using these methods, several S. elongatus proteins were detected but wild type 
and mutant samples showed the same labeling patterns (data not shown). 
Several antibodies are currently available to detect the O-GlcNAc modification 
(48). Western blots using these antibodies detected several proteins but did not 
reveal differences between the mutant and wild type (data not shown). Since S. 
elongatus PCC7942 has no other predicted OGTs, the proteins detected are 
either modified by a novel OGT or the antibodies are recognizing other structures 
as has been previously reported (37). Overexpression of SeOGT did not result in 
any detected phenotypes. In view of the failure of these approaches to identify O-
GlcNAcylation differences between wild type and ∆ogt, it is likely that 
glycoproteomic approaches employing mass spectrometry will be needed to 
identify the SeOGT substrates. Since prokaryotic substrates are not known, we 
attempted to modify a known eukaryotic OGT substrates using co-expressed 
SeOGT and Nup62 but did not detect modified substrates (data not shown), 
suggesting the enzyme either is not an OGT or that bacterial and eukaryotic 
OGTs have different substrate specificities.  
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DISCUSSION 
In addition to the eukaryotic-like OGTs, there are bacterial OGTs which 
have a different domain structure or share little sequence homology with the 
eukaryotic OGTs (Fig. 1B)(38, 49). The MrpC gene of the cyanobacteria 
Microcystis aeruginosa, which encodes a highly abundant extracellular protein 
that is important in cell-to-cell contact and may be O-GlcNAcylated, lies in a gene 
cluster with two proposed glycolsyltransferases, SlpA and SlpB (38). Both 
glycolsyltransferases share sequence homology with eukaryotic OGTs, but only 
SlpA contains TPR domains (Fig. 1B). However, SlpA’s TPRs have a different 
arrangement than eukaryotic OGTs. MrpC has two cellular variants: a secreted 
form and a form associated with the cell surface that is reported to be O-GlcNAc 
modified. While the O-GlcNAc modification is proposed to be important for cell 
surface retention, the effects of blocking the modification on protein localization 
have not been determined. Two bacterial flagellins that may be modified with O-
GlcNAc have been reported (36, 49). Listeria monocytogenes flagellins were 
found by mass spectrometry to contain several O-linked HexNAc modifications 
and immunostaining suggested the modifications were O-GlcNAc (33). However, 
the enzyme responsible for this modification remains unknown. Shen et al. (36) 
reported a bacterial OGT, GmaR, that interacts with a DNA-binding protein to 
regulate flagellar motility and can modify the flagellin. However, GmaR has no 
sequence homology to the catalytic region of eukaryotic OGTs. 
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While the crystal structure of a eukaryotic-like OGT from Xanthomonas 
campestris has been determined (21, 22), the cellular role(s) of this enzyme are 
unknown. In S. elongatus, deletion of the SeOGT does not affect the growth rate 
but causes several distinct phenotypes, suggesting the OGT affects multiple 
processes. Mutant cells settle out of media and aggregate to a greater extent 
than wild type (Fig. 3). The two phenotypes may be interrelated in that a defect in 
motility could lead to aggregation or vice versa. Marine strains of S. elongatus 
have motility despite having no known locomotion organelles such as flagella 
(50, 51). Several membrane-related mechanisms for S. elongatus motility have 
been proposed, including localized expansion and contraction of the cell 
membrane (52), acoustic streaming (53), mechanochemical filaments near the 
inner membrane causing surface waves (54), as well as a helical rotor model 
(55). In a Synechococcus species related to S. elongatus PCC 7942 several 
genes involved in motility (56), including ABC transporters, glycosyltransferases, 
and the cell-surface polypeptide, SwmA, which forms a glycosylated S-layer (57) 
have been identified. Although the motility genes SwmA and SwmB are not 
present in S. elongatus PCC 7942, cell surface proteins are likely to have a role 
in motility. Bacterial glycoproteins residing on the cell surface are often important 
in both motility-related structures such as flagella, as well as mediating cell-to-cell 
contact (31) and therefore could be SeOGT substrates. 
The ∆ogt settling phenotype is not due to a difference in buoyant density, 
as mutant and wild type cells had identical buoyant densities in a Percoll gradient 
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(Fig. 4). After treatment with sodium azide, which inhibits cytochrome oxidase 
and ATP synthesis, the wild type and mutant settling rates were similar  (Fig. 5). 
Interestingly, settling of ∆ogt was increased by sodium azide indicating that ∆ogt 
cells are only partially impaired in the ability to remain in suspension.  
TEM imaging reveals several macromolecular mutant phenotypes. Mutant 
cells show a widening of the thylakoid lumen (Fig. 6A, 6B) and a defect in the 
size and number of electron-dense bodies (Fig. 7A), which we hypothesized 
were polyphosphate bodies. However, we did not detect a change in the overall 
amount of phosphate in the form of polyphosphate suggesting the electron dense 
bodies are not polyphosphate bodies. Surprisingly, free inorganic phosphate was 
significantly higher in the ∆ogt strain (Fig. 7B), suggesting a defect in phosphate 
uptake or storage by the mutant. Supporting this hypothesis, when cells were 
transferred to phosphate poor media the settling rate of ∆ogt cells was 
unaffected, while that of wild type increased (Fig. 9). Supplementing the media 
with additional phosphate did not rescue the ∆ogt settling phenotype (data not 
shown). Since phosphate is a key limiting nutrient in many natural environments, 
regulation of sensing, uptake, and storage of phosphate in bacteria is tightly 
controlled by a process that involves phosphorylation of signaling proteins (58). 
Since O-GlcNAcylation and phosphorylation are reciprocal regulatory 
modifications in eukaryotes (42, 43), perhaps the interplay of O-GlcNAcylation 
and phosphorylation regulates phosphate status in bacteria. 
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 Mutational studies, as well as crystal structure models of OGTs with 
reaction components have led to identification of several critical amino acids (Fig. 
2). Although reintroduction of the native SeOGT gene rescued the settling 
phenotype, introduction of two genes with mutations predicted to impair catalytic 
activity did not fully rescue the phenotype (Fig. 8A). The H280A mutation, which 
affects a residue in or near the active site that possibly interacts with substrate 
proteins, prevented rescue. Likewise, the K445A mutation, which affects a 
residue predicted to stabilize the sugar donor, prevented rescue. In contrast, the 
G350D mutation affects the active site lid and cells expressing the mutant protein 
were weakly rescued. G350 is conserved in the Arabidopsis OGT SPY and is 
mutated to a D in the spy-12 mutant. Interestingly, the spy-12 mutation produces 
a weak phenotype suggesting that it causes only a partial loss of OGT activity 
(27). 
Since HsOGT has been reported to hydrolyze UDP-GlcNAc (23), the 
ability of SeOGT to hydrolyze UDP-GlcNAc was assessed. SeOGT hydrolyzed 
UDP-[3H]GlcNAc (Fig. 8B); furthermore, single amino acid mutations in the active 
site lid (G350D) and in the catalytic domain (K445A) significantly decreased this 
activity (Fig. 8B). These results support the homology of SeOGT with eukaryotic 
OGTs. Although the G350 residue resides in the active site lid, the reduction in 
activity may be due to instability in the binding pocket, or inhibition of access of 
the UDP-GlcNAc to the donor binding site. The reduction in activity for the K445 
residue is consistent with its predicted role to stabilize the UDP of the donor 
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sugar moiety in the active site. The loss of hydrolysis in these mutant enzymes 
and the inability of the mutant strains to fully rescue mutant phenotypes suggest 
that catalytic activity is required for SeOGT function. 
Interestingly, an additional active site mutant, H280A, did not have a 
significant difference in hydrolytic activity from wild type. In HsOGT this residue 
corresponds to H558, and is critical for modification of proteins . The residue was 
initially proposed to serve as a general base for catalysis , but was later found to 
be too distant from the acceptor hydroxyl to serve this role and therefore may not 
be directly involved in hydrolysis , which may explain why the mutant protein 
remains able to hydrolyze UDP-GlcNAc. The H280 strain did not rescue the null 
mutant settling phenotype (Fig. 8A), suggesting that although the mutant protein 
is able to hydrolyze UDP-GlcNAc it may be unable to transfer the sugar to the 
substrate protein. 
 The availability of a single celled system for the study of O-GlcNAcylation 
could accelerate research into the function of this protein modification. For this 
purpose, neither yeast nor E. coli are viable model organisms, as they lack OGT. 
The S. elongatus OGT has demonstrated mutant phenotypes suggesting multiple 
cellular roles, and can hydrolyze UDP-GlcNAc. Conserved amino acids important 
for OGT function in mammals and plants are also important in the SeOGT. 
Therefore, studies of the S. elongatus PCC 7942 OGT will potentially contribute 
to the understanding of both bacterial and eukaryotic OGTs. 
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MATERIALS AND METHODS 
Bacterial Growth.  
Cultures were grown in BG-11 media (59) with no antibiotics unless specified . 
Cultures were grown at 22°C under continuous fluorescent light (33.75 µmol 
photons m-2s-1) with aeration. To aerate, an aquarium air pump (Petco) was used 
to introduce bubbles to the bottom of culture flasks through a Pasteur pipette 
plugged with sterile cotton. 
Generation of OGT deletion and rescue strains.  
Constructs used to create deletion and rescue strains were made using MultiSite 
Gateway Three-Fragment vectors (Invitrogen) according to supplier’s protocols 
(see Table 1 for a list of all vectors and Table 2 for all primer sequences). Briefly, 
600bp of sequence directly upstream and 600bp directly downstream of the 
SeOGT gene (SynPCC7942_0051, GenBank ABB56083.1) were used to make 
pDONR SeOGT 5’ and pDONR SeOGT 3’, respectively, and a kanamycin 
resistance cassette was cloned into pDONR 221 to create pDONR Kmr. These 
constructs were used in a MultiSite Gateway reaction with pDEST R4-R3 vector 
to create pENTR ∆ogt::Kmr. This construct was transformed into S. elongatus 
PCC 7942 according to a previously established protocol (59). Homologous 
recombination resulted in replacement of the native gene with the antibiotic 
marker which was used to select for a deletion strain, Δogt::Km, noted as ∆ogt in 
figures. The genomic region was sequenced to confirm full deletion of the 
SeOGT.  
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The Synechococcus genome has two gene-free sites (neutral sites) where 
insertion of sequences does not cause any confounding downstream effects (59). 
For rescue experiments, wild type and mutant SeOGT genes under the control of 
the native promoter were introduced into neutral site two (NSII) of ∆ogt. The 
SoftBerry bacterial promoter prediction software BPROM (www.softberry.com) 
predicts that the SeOGT promoter is 293bp upstream of the start codon. Wild 
type SeOGT with 697bp directly upstream of the start codon was first fused to a 
streptomycin/spectinomycin cassette from pCDF Duet-1 (EMD-Millipore), in 
opposing orientation, using splice overlap extension PCR. This fusion was used 
to create pDONR pOGT:SeOGT-Specr. MultiSite Gateway cloning was used with 
the following vectors: pDONR  pOGT:OGT-Specr, pDONR NSII 5’, pDONR NSII 
3’, and pDEST R4-R3 and the resulting construct, pENTR pOGT:OGT-Specr, 
was transformed into ∆ogt. The resulting rescue strain Δogt::Kmr, 
NSII::pSeOGT:SeOGT-Specr (∆ogt:OGT in Figures) was selected using 
spectinomycin. Transformed colonies were screened and genotyped to confirm 
the presence of the expected sequences. After confirmation of a stable genotype, 
cultures were no longer grown under drug selection. 
 Mutant SeOGTs rescue constructs were created by splice overlap 
extension PCR using primers introducing mutations that create single amino acid 
changes (Table 2). The G350D mutant was then fused to a Strep/Specr cassette 
in opposite orientation to the SeOGT gene as described above for the ∆ogt:OGT 
strain. For other constructs, the Strep-Spec cassette was fused to the 
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downstream recombination region NSII 3’ in the pDONR NSII 3’ vector, resulting 
in pDONR NSII 3’-Specr vector. MultiSite Gateway was used to create the 
constructs used to generate these mutant OGT strains. The mutant strains 
Δogt::Kmr, NSII::pSeOGT:SeOGT G350D, Δogt::Kmr, NSII::pSeOGT:SeOGT 
H280A, and Δogt::Kmr, NSII::pSeOGT:SeOGT K445A, are noted in the figures as 
G350D, H280A, K445A, respectively. 
Culture Settling.  
To determine rates of settling, 1 mL of cultures at similar initial OD730 were 
transferred into 1 mL spectrophotometric cuvettes. The cuvettes were covered 
with parafilm and allowed to sit under continuous fluorescent light (33.75 µmol 
photons m-2s-1) without agitation or aeration. OD730 was measured at 24-hour 
intervals. Culture growth was determined using paired replicate cultures. Each 
day one of the replicate cultures was resuspended and OD730 was measured. In 
addition, growth was also monitored by dilution plating of the resuspended 
cultures on solid BG-11 media to determine colony-forming units. 
Cell Aggregation.  
Cultures were grown as described to exponential phase with aeration. 50 µL of 
cultures were diluted into 500 µL BG11 media, 50 µL of this dilution was applied 
to the well of a hemocytometer with a cover slip, and allowed to sit at 22°C for 20 
minutes. Cells were then counted as either single cells or cell clusters with the 
exception of cells with end-to-end contact, which could represent newly divided 
cells.  
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TEM Imaging.  
For TEM imaging, exponential cultures fixed with 3% glutaraldehyde were 
prepared for Transmission Electron Microscopy (TEM) with osmium tetroxide 
staining according to the methods at Cyanosite (http://www-
cyanosite.bio.purdue.edu/protocols/semithin.html) and sectioned. Cells were 
visualized using a Philips CM12 Transmission Electron Microscope and digitally 
photographed. Image J software (http://rsbweb.nih.gov/ij/) was used to measure 
the width of the lumen of cells that presented as round, mid-cell cross-sections. 
Production of Saccharomyces cerevisiae exopolyphosphatase PPX1.  
The exopolyphosphatase PPX1 from Saccharomyces cerevisiae was cloned into 
the expression vector pET11c (Invitrogen), expressed in E.coli cells (Rosetta, 
Novagen) and purified according to Wurst et al. (60). Enzymatic activity was 
confirmed using commercially synthesized polyphosphate (sodium phosphate 
glass type 45, Aldrich).  
Inorganic phosphate measurements.  
S.elongatus cultures were grown to exponential phase and cells were pelleted by 
centrifugation for 15 minutes at 3700xg in a JA-20 rotor (Beckman). The cell 
pellets were frozen at -80°C, thawed, and re-suspended in French Press Buffer 
consisting of 20mM Tris-HCl (pH 7.5), 2mM EDTA, 1M sodium perchlorate, 1% 
SDS w/v (61) and cells were disrupted via two passes through a French Press. 
Cellular debris was cleared by centrifugation at 4°C for 15 minutes, at 20,000xg 
in a JA-20 rotor (Beckman) and aliquots of the supernatant were frozen at -20°C.  
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 Free inorganic phosphate and phosphate in polyphosphate bodies were 
determined using a modified protocol from Werner et al. (46). 50 µL of cell lysate 
was added to 50 µL 1M sulfuric acid and vortexed briefly. The mixture was 
incubated for five minutes, then neutralized with 50 µL 2M sodium hydroxide and 
100 µL Red Tris solution (1M Tris-HCl (pH 7.5), 6% Neutral Red solution (Ricca 
Chemical Company, Arlington TX), vortexed, then centrifuged to remove 
precipitated proteins. pH was assessed via color test and adjusted to neutral 
(acidic solutions are pink, basic solutions are yellow and neutral pH solutions are 
pinkish-orange). 50 µL aliquots of this neutralized solution were transferred to 
two separate microcentrifuge tubes. One aliquot was used to determine free 
inorganic phosphate and the other was used to determine total inorganic 
phosphate (free plus polyphosphate). Polyphosphate in one sample was 
hydrolyzed at 37°C following the addition of 142 µL of reaction buffer (20mM Tris-
HCl (pH 7.5), 5mM magnesium acetate, 5mM ammonium acetate) and 8 µL 
PPX1. A pilot experiment indicated the hydrolysis was complete after 60 minutes 
so samples were incubated for 60 minutes. In some cases, additional 
polyphosphate was added and the reaction was extended for an additional 60 
minutes to confirm that the reaction was not enzyme-limited. The aliquot used to 
measure free inorganic phosphate was treated similarly to the total phosphate 
sample except that PPX1 was omitted.  
 To measure phosphate in these samples, 344 µL of 28mM ammonium 
heptamolybdate in 2.1M sulfuric acid was added to each tube and tubes were 
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incubated for 20 minutes at 22°C. To develop color, 256  µL of 0.76mM malachite 
green oxalate in 0.35% polyvinyl alcohol was added to each sample and 
incubated for 20 minutes at 22°C. Absorbance at 595 nm was then measured. A 
standard curve using fresh potassium phosphate solutions was created for each 
experiment. The amount of inorganic phosphate as polyphosphate was 
calculated by subtracting the amount of free inorganic phosphate from the 
amount of total phosphate. 
Expression and purification of SeOGT.  
Wild type and mutant SeOGT were expressed as MBP-fusion proteins using 
pRARE-MBP-DEST  in E. coli BL21(AI) cells. Proteins were purified on amylose 
columns according to the manufacturers recommendations (NEB), with the 
exception of removal of salt in the final wash, and flash frozen at -80° C in 20% 
glycerol. Coomassie-stained SDS PAGE gels indicated that approximately 90% 
of the protein in each preparation was full length SeOGT (data not shown). 
Enzyme catalyzed hydrolysis of UDP-GlcNAc.  
Purified SeOGT-MBP enzyme was tested for the ability to hydrolyze radiolabeled 
UDP-[3H]GlcNAc in an assay modified from Support Protocol 4 in Zachara et al. 
(48). A UDP-[3H]GlcNAc solution was made by drying 2 µCi of 2 mCi/ mL UDP-
[3H]GlcNAc  (Specific Activity 20-45 Ci, 0.74-1.66 TBq/mmol, Perkin Elmer) under 
argon and resuspending it in 2 µL of 25mM adenosine mono-phosphate and 48 
µL of 50mM Tris (pH 6.8), 5mM MnCl2, 0.5uM UDP-GlcNAc. Each 50 µL reaction 
included 5 µL of the UDP-[3H]GlcNAc solution (0.2 µCi per reaction), 6 µg 
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purified enzyme,  50mM Tris-HCl (pH 7.4), 1mM DTT, 12.5mM MgCl2. The 
reaction incubated at 30°C and was stopped with the addition of 500 µL H2O. In 
all experiments, reactions were run for 2 hours because a preliminary time 
course experiment indicated that reactions with wild type enzyme were 80% 
complete at this time (determined by time course). After termination, the reaction 
was immediately loaded onto Dowex AG1 resin (PO4 form) columns, which 
retains UDP-GlcNAc. The column was washed with 3 mL H2O, and radioactivity 
in the wash was measured using a Packard Tri-Carb 2900TR liquid scintillation 
counter. 
Preparation of protein samples for antibody probing, GalT, and BEMAB 
20 mL cultures were collected and gently pelleted. Pellets were stored overnight 
at -20C. Cells were resuspended in 1 mL cold bead beating buffer (20 mM Tris-
HCl (pH 8.0), 5 mM EDTA). 10 µL of PMSF and 10 µL of PUGNAc were added, 
with a small addition of glass beads. Samples were flash-frozen in liquid nitrogen, 
thawed in a 37°C water bath, then vortexed for 30 seconds, four times, with a 30 
second rest in ice in between each vortexing. These steps were repeated three 
times. Samples were spun at 4K rpm in Beckman JA18.1 rotor for 1 minute. 750 
mL supernatant was collected, centrifuged at 10K for 15 minutes. Resulting 
supernatant was saved as soluble protein sample. Pellet from 1st spin was 
resuspended in 1 ml cold bead beating buffer, with 50 µL 25% Triton. Samples 
were vortexed every 5 minutes for 30 minutes with rest on ice in between 
vortexing. Samples were centrifuged at 10K for 15 minutes, and 200 µL 
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supernatant was collected as thylakoid membrane sample. The remaining pellet 
was used as insoluble sample. All sample fractions were boiled 5 minutes in 
SDS-PAGE loading buffer and stored at -20°C. Some samples were frozen 
overnight at -80°C and run through French Pressure Cell two times in either bead 
beating buffer or French Press Buffer (61). Soluble and insoluble samples were 
collected. 
Antibody probing. 
Samples were run on 12% polyacrylamide gels and Coomassie stained, or run 
on gels and transferred to PVDF membrane for antibody probing.  
Probing with anti-GlcNAc CTD110.6 was performed as described in Zachara 
(48). Probing with additional antibodies was performed as described in Teo et al. 
(62). 
Galactosyl transferase assay (GalT). 
Samples were run on SDS-PAGE gels and transferred to PVDF membrane. 
Membrane was blocked overnight at 4°C in 3% bovine serum albumin in 10 mM 
HEPES (pH 7.9).  Membrane was washed in 10 mM HEPES (pH 7.9) for 10 
minutes with gentle shaking. Three µCi of UDP-H3-Galatose were dried under 
argon and resuspended in 3 µL 25 mM adenosine monophosphate and added to 
800 µL labeling buffer (10 mM HEPES (pH 7.9), 1M MnCl2 , 1% BSA, protease 
inhibitor, and 100m units calf intestinal phosphatase. The membrane was sealed 
in plastic and incubated for 3 hours at 37°C. The membrane was washed 7 times 
for 10 minutes each in 10 mM HEPES (pH 7.9). The membrane was dried and 
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sprayed with EN3HANCE (PerkinElmer) and dried for 20 minutes. The membrane 
was placed on pre-flashed film, then sealed and placed at -80°C for 72 hours. 
BEMAB. 
Samples were run on 15% SDS-PAGE gels and transferred to PVDF membrane. 
In a technique adapted from Wells et al. (63), the blot was incubated in 5 mL of 
1% triethylamine, 0.1% NaOH, 3 mM 50 mM 5-(biotinamido)pentylamine. The 
blot was then incubated at 37 C for 24 hours with gentle agitation. The blot was 
washing with ddH20, blocked in PBS with 0.05% Tween and 3% BSA, and 
probed with Streptavidin-HRP, which was detected by chemiluminescence. 
Overexpression of SeOGT. 
GeneArt Synechococcus TOPO kit (LifeTechnologies) was used to create an 
inducible overexpression line. (Primers  SeOGT pSyn F 
caccatgagtactcaggacaacag 
SeOGT pSyn R tcaaaatctaacttctttattggcgctc). PCR and transformation of E. coli 
and Synechococcus performed as recommended by kit. The overexpression 
cassette was transformed into the Neutral Site I of the ∆ogt. This nickel-induced 
promoter is weakly constitutive and was found to be active enough to rescue 
mutant phenotypes without induction. However, to determine overexpression 
effects, 5 µM NiCl2 was added as per kit instructions to growing cultures, and 
cultures were examined for phenotypes.  
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Coexpression of SeOGT with Nup62. 
SeOGT-MBP was purified as previously explained. 20 µg SeOGT-MBP and 20 
µg purified E.coli-expressed Nup62-His were added to 30 µL reaction buffer (50 
mM Tris (pH 7.4), 1 mM DTT, 12.5 mM MgCl2, 0.5 mM Tris (pH 6.8), 5 mM 
MnCl2, UDP-GlcNAc). The mix was incubated at 30°C for 1 hour, then run on an 
SDS-PAGE gel and stained to look for band shifts of heavily O-GlcNAcylated 
Nup62. 
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Table 1. Plasmids and strains used and created in this study. 
Plasmids used in this study Description of use  
pDONR221 DONR vector for Three Way Gateway Cloning 
pDONR P4 P1 DONR vector for Three Way Gateway Cloning 
pDONR P2 P3 DONR vector for Three Way Gateway Cloning 
pDEST R3 R4 DEST vector for Three Way Gateway Cloning 
pDONR 221  Source of Kmr gene 
pCDF_Duet Source of Spr gene 
pRARE-MBP-DEST Used for protein expression 
   
Plasmids created in this study Source Plasmid Description 
pDONR Kmr pDONR221 Kanamycin resistance cassette  
pDONR SeOGT 5' pDONR Upstream region of SeOGT for deletion 
pDONR SeOGT 3' pDONR Downstream region of SeOGT for 
deletion 
pENTR ∆ogt::Kmr pDEST R3 R4 Final construct for SeOGT deletion 
transformation 
pDONR NSII 5' pDONR P4 P1 Upstream region of NSII for introduction 
of genes 
pDONR NSII 3' pDONR P2 P3 Downstream region of NSII for 
introduction of genes 
pDONR NSII 3'-Specr pDONR P2 P3 Downstream region of NSII for 
introduction of genes, fused to 
Spectinomycin resistance cassette 
pDONR pOGT:SeOGT-Specr pDONR 221 SeOGT and native promoter, fused to 
Spectinomycin resistance cassette 
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pENTR pOGT:SeOGT-Specr pDEST R3 R4 Final construct for ∆ogt:SeOGT rescue 
strain 
pDONR SeOGT G350D pDONR 221 Mutant constructs for ∆ogt rescue 
pENTR SeOGT G350D pDEST R3 R4 " 
pDONR SeOGT H280A pDONR 221 " 
pENTR SeOGT H280A pDEST R3 R4 " 
pDONR SeOGT K445A pDONR 221 " 
pENTR SeOGT K445A pDEST R3 R4 " 
pRARE SeOGT pRARE Protein expression of SeOGT in E. coli 
pRARE SeOGT G350D pRARE Protein expression of SeOGT G350D in 
E. coli 
pRARE SeOGT H280A pRARE Protein expression of SeOGT H280A in 
E. coli 
pRARE SeOGT K445A pRARE Protein expression of SeOGT K445A in 
E. coli 
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Table 2. Primers used in this study 
 
Name Sequence  Purpose of primer pair 
Kan-R replacement B1F GGGGACAAGTTTGTACAAAA
AAGCAGGCTTCCGTGTCTCA
AAATCTCTGATGT 
Replacing SeOGT with KanR 
cassette 
Kan-R replacement B2R GGGGACCACTTTGTACAAGA
AAGCTGGGTAATGAGCTTGC
GCCGTCCCGTCA 
 
SeOGT 5' B4F GGGGACAACTTTGTATAGAA
AAGTTGCCTCATGGGTCGAC
ATCATTAAAT 
5' upstream region around 
SeOGT to allow for homologous 
recombination 
SeOGT 5' B1R GGGGACTGCTTTTTTGTACA
AACTTGCCATAGATTCATTTA
ACTGCAAC 
 
SeOGT 3' B2F GGGGACAGCTTTCTTGTACA
AAGTGGCCGATTTTGATATG
ATGAGCAATC 
3' downstream region around 
SeOGT to allow for homologous 
recombination 
SeOGT 3' B3R GGGGACAACTTTGTATAATA
AAGTTGCAAACACTTCCAAC
AACAGCACC 
 
Synecho NSII 5’ B4F GGGGACAACTTTGTATAGAA
AAGTTGCCACCCCACGATTC
TGAGCTTA 
5' upstream region around 
neutral site II to allow for 
homologous recombination to 
create transgenes 
Synecho NSII 5’ B1R GGGGACTGCTTTTTTGTACA  
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AACTTGCGCTTCAAGATTCG
GCAGTGA 
Synecho NSII 3’ B2F GGGGACAGCTTTCTTGTACA
AAGTGGCCAACCGTTCCTGC
GCGATCGCT 
3' downstream region around 
neutral site II to allow for 
homologous recombination to 
create transgenes 
Synecho NSII 3’ B3R GGGGACAACTTTGTATAATA
AAGTTGCGCGCCCAGTGGA
AACAACTGT 
 
Synecho pOGT:OGT B1F GGGGACAAGTTTGTACAAAA
AAGCAGGCTTCTCAAAATCT
AACTTCTTTAT 
SeOGT for creating transgene 
rescue into neutral site II 
Synecho OGT B2R TCCATTTCATGAATAAGTTGA
ATAATTACCAACAGATTAG 
 
SpecR F CAACTTATTCATGAAATGGA
CTGTCAGATTCATGGTTGAG
CC 
Spectinomycin resistance 
cassette to fuse to NSII 3' 
region to confer resistance to 
inserted genes 
SpecR B2R GGGGACCACTTTGTACAAGA
AAGCTGGGTATCACACTGCT
TCCGGTAGTC 
 
SpecR B2F GGGGACAGCTTTCTTGTACA
AAGTGGCCATTTGTTTATTTT
TCTAAATAC 
Spectinomycin resistance 
cassette to fuse to NSII 3' 
region to confer resistance to 
inserted genes 
SpecR Overlap R CGCGCAGGAACGGTTTAGT  
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GTGTTATTTGCCGACTACC 
NSII 3’ Overlap F CACACTAAACCGTTCCTGCG
CGATCGCTCTTACTG 
NSII 3' region to fuse with 
Spectinomycin resistance 
cassette 
NSII 3’ B3R GGGGACAACTTTGTATAATA
AAGTTGCCGCGCCCAGTGG
AAAC 
 
SeOGT pRare F GGGGACAAGTTTGTACAAAA
AAGCAGGCTTCATGCAGTTA
AATGAATCTATGAGT 
Protein expression of SeOGT in 
E.coli 
SeOGT pRare R GGGGACCACTTTGTACAAGA
AAGCTGGGTTCAAAATCTAA
CTTCTTTATTGGC 
 
SeOGT G350D Overlap F CTTATTGAGCTTTCTGACCAT
ACAAATGGTAAC 
Overlap PCR to create G350D 
mutant 
SeOGT G350D OverlapR GTTAACATTTGTATGGTCAG
AAAGCTCAATAAG 
GGA (Gly) to GAC (Asp) 
SeOGT H280A Overlap F GAAATAACTTACGGAGGCTG
TTTTAAAATCACCC 
Overlap PCR to create H280A 
mutant 
SeOGT H280A Overlap R GGGGTGATTTTAAAACAGCC
TCCGTAAGTTATTTC 
CAT (His) to GCG (Ala) 
SeOGT K445A Overlap F GAATAGTCACTAATTGCTCG
ACTTGCAACG 
Overlap PCR to create K445A 
mutant 
SeOGT K445A Overlap R CGTTGCAAGTCGAGCAATTA
GTGACTATTC 
AAG (Lys) to GCA (Ala) 
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Table 3. Colony forming units of wild type and null mutant. 
 
 Colonies grown 
from Dil 1x106 
Colonies grown 
from Dil 1x105 
CFUs/mL 
WT 27 204 2.37x107 
∆ogt 23 224 2.27x107 
 
Wild type and ∆ogt mutant cultures were grown to mid-exponential phase under 
aeration, then allowed to sit with no aeration or shaking for 5 days. Cultures were 
shaken to resuspend settled cells and plated in dilution series. After two weeks, 
colony forming units (CFUs) were counted. Mutant and wild type cultures share a 
similar growth rate, despite mutant cell settling. 
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Figure 1. Domain organization of eukaryotic-like OGTs. (A) Structure of 
metazoan OGTs, showing N-terminal TPR repeats and two catalytic regions 
divided by a variable linker region. (B) Structure of putative prokaryotic OGTs: 
Synechococcus elongatus PCC7942, Xanthomonas campestris campestris, 
Geobacter sp. M21, Thiorhodovibrio sp. 970, Bradyrhizobium japonicum, 
Microcystis aeruginosa. Gray shading indicates homology to the eukaryotic 
catalytic domain. Asterisk indicates enzymes with non-eukaryotic domain 
structures. The catalytic domain of the Bradyrhizobium protein and M. 
aeruginosa SlpA and SlpB show homology to the Arabidopsis OGT SEC, but 
have an uncharacteristic TPR distribution. TPRs were predicted using TPRpred 
(http://toolkit.tuebingen.mpg.de/tprpred). 
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Figure 2. Alignment of OGT active sites. 
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Figure 3. Mutant cells settle and aggregate. (A) Early exponential phase cultures 
were transferred to a cuvette and allowed to sit without agitation for 0 or 4 days 
before photographing. (B) Early exponential phase cultures were transferred to a 
cuvette and allowed to sit without agitation and optical density (OD730) was 
measured daily (bars). To monitor growth rate, cells in duplicate cuvettes were 
resuspended before measuring the OD730 (lines). (C) Cells were placed on a 
hemocytometer slide for 20 minutes and photographed at 100x. The arrows 
indicate aggregated cells. The scale bar = 2  µM. (D) The fraction of cells (WT, 
n=1934; ∆ogt, n=1964; ∆ogt::OGT, n=1968) in aggregates of two or more was 
determined. In panels B and D, the data represent the results from three 
complete biological replicates with the error bars indicating the standard error.  
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Figure 4. Centrifugation in a Percoll gradient shows that wild type and ∆ogt cells 
have identical buoyancies. 1.5 mL PBS. 0.5 mL culture were gently pelleted, then 
resuspended in 0.5 mL PBS. Samples were overlayed in tubes on 8 mL Percoll 
(Amersham). The tubes were centrifuged in a Ti75 rotor (Beckman) at 20,000 
rpm for 2 hours at 4°C. 
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Figure 5. Wild type and ∆ogt cells settle faster under treatment with 0.05% 
sodium azide. Experiments were run at a range of initial densities. This figure is 
representative of other experiments. 
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Figure 6. The ∆ogt mutant has a wider thylakoid lumen. (A) TEM images show 
∆ogt mutant cells sharing typical cell structure with concentric thylakoids around 
a central chamber, but display wider thylakoid lumen (arrows). Scale bar = 200 
nm (B) The thylakoid lumen width of wild type, ∆ogt mutant, and ∆ogt rescued 
with a SeOGT transgene. One-way ANOVA analysis with standard error of 16 
cells per strain reveals that the thylakoid widths are statistically different (p<0.05) 
from each other. 
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Figure 7. The ∆ogt mutant has aberrant electron dense bodies and accumulates 
inorganic phosphate. (A) ∆ogt mutant cells display an increase in electron dense 
bodies (arrows) distributed between the exterior of concentric thylakoid 
membrane pairs. The scale bar = 250 nm. (B) Free inorganic phosphate and 
inorganic phosphate released from polyphosphate bodies (PPBs) by 
exopolyphosphatase were quantitated. Although there is no difference in the 
amount of inorganic phosphate released from polyphosphate, mutant cultures 
contained nearly three-fold more free inorganic phosphate. The data represent 
the results from three complete biological replicates with the error bars indicating 
the standard error. 
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Figure 8. Catalytic region mutations affect SeOGT activity. (A) Wild type and 
mutant SeOGT genes were introduced into the ∆ogt null mutant and the resulting 
strains were tested for rescue of the settling phenotype.  Wild type OGT rescues 
the settling phenotype, H280A and K445A SeOGT do not and G350D weakly 
rescues. (B) Catalytic region mutations affect hydrolysis of UDP-GlcNAc. Wild 
type and mutant MBP-fusion proteins were purified. Enzymatic activity was 
measured based on the amount (DPM) of [H3]GlcNAc released from UDP-[ 
H3]GlcNAc. The values shown are after subtraction [H3]GlcNAc produced in a 
reaction with purified MBP-GFP. Reactions were performed in triplicate and 
analyzed by one-way ANOVA. Different numbers of asterisks indicate that the 
values are different (p<0.05). In both A and B, the error bars indicate the 
standard error. 
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Figure 9. In phosphate-poor media wild type cells settle. The settling rate of ∆ogt 
cells is not affected. Cultures were grown to OD730 0.5, gently centrifuged, and 
resuspended in BG-11 media made without K2PO4, then allowed to settle in 
cuvettes.  
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Chapter Three 
A missense mutation in PilA suppresses multiple mutant phenotypes in the 
O-GlcNAc transferase deletion strain of Synechococcus elongatus 
PCC7942 
 
INTRODUCTION 
  In bacteria, glycans can be added to proteins via O-linkages to serine or 
threonine residues, or by N-linkage to asparagine residues, and can be 
constructed sequentially or en bloc (64). Bacteria boast a wide variety of glycans 
due to the diversity of both the monosaccharides used, and resulting glycan 
configurations. The cell surfaces of diverse bacteria host an array of 
glycoproteins, which are used in virulence, adhesion, and motility. 
In mammals, an important glycosylation is the addition of a single O-linked 
N-acetylglucosamine (O-GlcNAc) to the hydroxyl group of a serine or threonine 
residue. In metazoans, this modification has been implicated in a wide variety of 
cellular roles, including cell signaling, proteasome degradation, and gene 
transcription. Similar to phosphorylation, O-GlcNAcylation is dynamic. Unlike 
phosphorylation, which has a large variety of kinases and phosphatases to 
enable this cycling, O-GlcNAcylation commonly has only one enzyme for 
addition, O-GlcNAc transferase (OGT), and one enzyme for removal, O-GlcNAc 
hydrolase (OGA). Interestingly, the O-GlcNAc modification has been reported to 
compete with phosphorylation on the same residues. Numerous bacterial 
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genomes contain genes encoding for homologs of the eukaryotic OGT and/or 
OGA, but the cellular roles of these enzymes and O-GlcNAc modification in 
bacteria remain unclear. 
 The OGT of the cyanobacterium Synechococcus elongatus PCC 7942 has 
previously been shown to have hydrolytic activity against the sugar donor, UDP-
GlcNAc (Chapter Two) (28). Mutant phenotypes have suggested varied cellular 
roles for the enzyme. ∆ogt mutants exhibit a range of seemingly unrelated 
phenotypes such as settling, larger electron-dense bodies, wider thylakoid 
lumen, and high inorganic phosphate levels. The substrates targeted by SeOGT 
involved in these phenotypes are unknown, as are the roles of the modification. 
Type IV pili (T4P) are polymeric filaments found on the surface of many 
Gram negative bacteria that have multiple functional roles, including 
pathogenesis, DNA uptake, adhesion, and twitching motility. Pili consist of a 
homopolymer of the small protein PilA arranged helically, which can be 
dynamically extruded or retracted through the addition or subtraction of PilA units 
via assembly ATPases (PilB, PilF), and disassembly ATPases (PilT, PilU). 
Although the precise mechanisms for polymerization and retraction are not yet 
known, a core group of highly conserved assembly proteins are critical for pilus 
assembly, including the PilA subunits, assembly/disassembly ATPases, the core 
protein PilC, and the secretin channel protein PilQ (see Giltner et al. 2012 (65) 
for review). Regulation of pili production occurs at the transcriptional level as well 
as the posttranslational level. Pili are modified by glycosylation, most frequently 
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via O-glycosylation, which can modulate pili function (65). Defects in different 
types of glycosylation affect motility, host cell invasion, pilus assembly and 
others. Synechococcus elongatus PCC 7942 has two adjacent annotated pilA-
like genes (Synpcc7942_0048 and 0049), however it has been reported that the 
pilA distal to the predicted promoter region, Synpcc7942_0048, is not commonly 
active (66). 
 
RESULTS 
Suppressor strain. 
In the course of growing cultures, a culture of ∆ogt was observed to no longer 
exhibit the settling phenotype. I hypothesized that the culture had a spontaneous 
suppressor mutation. The strain was isolated and genotyped to confirm the ∆ogt 
mutation was present and that there was no evidence of the wild type OGT gene. 
Characterization of suppressor phenotypes. 
The suppressor mutant was tested for other phenotypes of the ∆ogt mutant. 
Although ∆ogt cultures settle out of media, both wild type and the suppressor 
strain do not (Fig 1A). ∆ogt cells aggregate to a greater extent than wild type, and 
the suppressor strain was suppressed for this phenotype as well (Fig. 1B). To 
determine whether other mutant phenotypes are suppressed by this mutation, I 
analyzed the inorganic phosphate content of cells. ∆ogt cells have a nearly two-
fold increase in inorganic phosphate, but surprisingly, this phenotype was not 
suppressed in the suppressor strain (Fig. 2).  
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Whole genome sequencing reveals a SNP in pilA.  
Genomic DNA was purified from wild type, ∆ogt, and the suppressor strain and 
submitted for whole genome sequencing. Upon comparison, a single nucleotide 
polymorphism (SNP) between ∆ogt and the suppressor genomes was identified. 
This guanine to thymine transversion results in an amino acid change from 
alanine to aspartic acid (A107D) in the promoter-proximal gene of the tandem 
pair of pilA-like genes (SynPCC7942_0049, GenBank ABB56081.1) (Fig. 3A, B). 
The suppressor strain is referred to as ∆ogt, pilA(A107D). 
The A107D mutation rescues the ∆ogt settling and pili defect.  
PilA is the major structural protein that comprises pili. To study the effects of the 
mutation on pili formation, we performed a Congo Red (CR) assay that takes 
advantage of Congo Red’s affinity for pili (67). In this assay whole cells are 
exposed to CR. The residual CR in the supernatant is measured after removal of 
cells. Surprisingly, the ∆ogt mutant displayed a significant decrease in CR 
binding compared to wild type, suggesting fewer pili. The ∆ogt, pilA(A107D) 
mutation showed reversion to wild type CR binding levels, suggesting restoration 
of pili formation (Fig. 4A). These results led us to perform electron microscopy 
imaging to observe pili on whole cells. Consistent with the CR results, TEM 
imaging revealed pili on wild type and suppressor cells, but showed that ∆ogt 
cells were almost completely devoid of pili (Fig 4B).  
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Transgene rescues.  
To investigate the interactions between OGT and PilA in pilA(A107D), several 
transgene constructs were made. Transgene rescue of ∆ogt, pilA(A107D) with the 
wild type OGT gene has no effect on CR binding (Fig 5A). Interestingly, 
introduction of a wild type PilA gene into ∆ogt, pilA(A107D) reduced CR binding. 
Introduction of pilA(A107D) into wild type cells also reduced CR binding, suggesting 
a lack of pili. 
Introduction of wild type pilA into ∆ogt, pilA(A107D)  resulted in reversion of 
the settling phenotype to that of the ∆ogt null mutant (Fig 5B). Introduction of 
pilA(A107D) into the wild type strain phenocopied the ∆ogt mutant. Congo Red 
assays reveal that when both wild type PilA and pilA(A107D) are expressed 
together pili production is inhibited. The ability of pilA(A107D) to cause settling when 
introduced to wild type suggests that the mutant and wild type PilA interfere with 
each other. 
Pili are O-glycosylated with GlcNAc terminal modification.  
To determine the glycosylation state of wild type, ∆ogt, and ∆ogt, pilA(A107D) pili 
were purified. Purified pilus proteins were run on 15% SDS-PAGE gels and 
Coomassie stained. Very little protein was detected near the predicted size of pili 
on the stained gel in the ∆ogt strain. Proteins on the SDS-PAGE gel were 
transferred to a nylon membrane for β-elimination Michael Addition with Biotin 
(BEMAB). This reaction replaces terminal O-linked moieties with a biotin 
molecule, which is detected using HRP-conjugated streptavidin. A protein of the 
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predicted pilin size, 15kD, was detected in wild type and ∆ogt, pilA(A107D), but was 
not detected in the ∆ogt pilin preparation (Fig. 6). Interestingly, both wild type and 
the ∆ogt, pilA(A107D) showed a strong BEMAB signal, indicating O-linked 
modifications are present on both pili. Despite there being a small amount of 
protein on the SDS-PAGE gel detectable by staining, the null mutant did not 
return any BEMAB signal, suggesting loss of an O-linked moiety on pili in this 
strain or that the 15kD protein in ∆ogt preparations is not PilA. 
An assay to detect glycans was also performed in which glycans are 
oxidized with periodate on a blot, and detected by a reaction with biotin hydrazide 
followed by immunostaining. This assay labeled a protein of the predicted pilin 
size (Fig. 7). After β-elimination to remove O-linked glycans, the wild type band 
faded, but the ∆ogt, pilA (A107D) band was much more prominent. This may be a 
result of N-glycans taking the place of O-glycans in the absence of SeOGT. The 
suppressor may therefore have a different ratio of N- and O-linked glycans. 
To determine whether the O-linked modification is a terminal O-GlcNAc, 
we performed an on-the-blot GalT reaction, wherein purified pili are run on SDS-
PAGE gel, then transferred to a nylon membrane and exposed to galactosyl 
transferase (GalT) which transfers a 3H-galactose to a terminal O-GlcNAc. Bands 
are apparent for wild type and ∆ogt,pilA(A107D) (Fig. 8). After β-elimination to 
remove O-linked glycans, no signal was obtained from either of the strains, 
indicating a terminal O-linked GlcNAc. 
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DISCUSSION 
 A spontaneous suppressor of ∆ogt mutant phenotypes in S. elongatus 
was identified. Whole genome sequencing uncovered a SNP in the pilA gene, 
resulting in the mutation pilA(A107D). Electron micrograph imaging revealed a loss 
of pili in ∆ogt, and suppression of this phenotype in ∆ogt, pilA(A107D), supporting 
the role of pilA(A107D) as a suppressor of ∆ogt phenotypes (Fig. 4B). It has been 
well established that many bacterial glycoproteins reside on the cell surface, so it 
is no surprise that the mutation suppressing the glycosyltransferase mutant 
phenotypes is a cell surface protein. Similar to flagella, T4Ps have been shown to 
be posttranslationally modified with a variety of glycans and some of these 
modifications are critical for several functions including motility, host cell invasion, 
pilus assembly and others (68, 69). The most common T4P modification, beyond 
the removal of the N-terminal signal sequence, is O-glycosylation, which can 
modulate pili function.  
Wild type pili require the presence of OGT to produce pili, but the 
requirement for OGT is alleviated in the pilA(A107D) strain. If PilA subunits are 
directly modified by OGT, this result may be due to changes in conformation or 
changes in other local glycan modifications in the ∆ogt, pilA(A107D) strain that allow 
subunits to appropriately interact. Although the precise mechanism for pili 
assembly and production remains unclear, several key parts of the process are 
known. In one model suggested by Craig and Li (70), PilA subunits are first 
posttranslationally modified by cleavage of the signal sequence followed by 
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methylation of the N-terminus. Then PilA units remain as a pool anchored to the 
inner membrane via their hydrophobic α-helices and may be attracted to the 
base of the assembly mechanism by chemical complementarity of both the N-
terminal region and the globular domains. The filament is extruded subunit by 
subunit by a cytoplasmic ATPase, PilB, through a secretin channel. Considering 
this model, defects in either PilA availability, PilA/PilA interaction, or some other 
aspect of the assembly mechanism could lead to a loss of pili. 
The introduction of wild type pilA gene into the ∆ogt, pilA(A107D) strain 
inhibits pili production. Similarly, introduction of pilA(A107D) to wild type strain also 
inhibits pili. Inability to assemble pili with two types of PilA subunit may result 
from non-compatible subunit interaction, inhibiting homopolymer interaction. Pili 
defects may also be a result of defects in assembly machinery, as PilA interacts 
with pili subunits PilC, PilD, PilF and PilG to form a pilus. Pili require a complex 
set of proteins for assembly, which are generally well-conserved in Gram 
negative bacteria.  These include the PilA subunits, PilC inner membrane core 
protein, PilQ outer membrane secretin channel, and two ATPases, PilB and PilT, 
devoted to both assembly and retraction, respectively, as well as several other 
accessory proteins and chaperones. An in situ chemical crosslinking study 
suggests that several of these components form a large complex linking both the 
inner and outer membranes (71). Defects in glycosylation of any of these 
components may prevent assembly. 
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PilA levels are regulated at the transcriptional level by a two-component 
system consisting of PilR and PilS. PilR binds the RpoN-RNA polymerase 
complex at the σ54-dependent promoter of PilA and acts as an enhancer protein, 
allowing transcription to occur. PilR requires phosphorylation by the membrane-
bound histidine kinase PilS, which responds to a yet unknown signal and 
autophosphorylates before acting on PilR. Studies of pilin gene transcription 
showed an increase in a pilA transcriptional reporter in pilin mutants, suggesting 
that PilA may negatively self-regulate expression . If PilA subunits are available 
at the inner membrane for assembly, but assembly is inhibited, either by defects 
in subunit interaction or by assembly mechanism defects, the unused PilA pool in 
the inner membrane may negatively regulate further pilA transcription. A defect in 
the PilR-PilS system may also negatively regulate pilA transcription, leading to 
loss of pili. 
T4P pilin sequences show low conservation across species, except for 
several key regions. A variable leader peptide is followed by a distinctive and 
highly conserved cleavage sequence. At the N-terminus, the hydrophobic  α-helix 
region serves as a transmembrane anchor to retain individual subunits at the 
ready for processing, and as the core of the final pilus. An amphipathic 
subdomain packs against a variable-length anti-parallel β sheet region, forming a 
globular head.  Although sequences of these globular regions are divergent, the 
general structure remains conserved. The final C-terminal proximal loop is the 
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disulfide-bond loop, or the D-loop, created by cysteine-cysteine interactions, 
which is critical for pilus assembly and function (72). 
 Consistent with T4P, PilA of Synechococcus elongatus PCC7942 has the 
conserved cleavage signal sequence, and is predicted to form two N-terminal α-
helix subdomains, followed by β sheets. The pilA(A107D) mutation in the 
suppressor strain is located near the predicted D-loop (Fig. 3). Mutations in the 
D-loop have been reported to affect pilus assembly and motility (72, 73), 
phenotypes seen in the ∆ogt strain. Although the suppressor has an intact D-loop 
region, the pilA(A107D) mutation may result in aberrant local structure, leading to 
instability of the D-loop. The pilA(A107D)  mutation results in suppression of the pili 
assembly and motility phenotypes in ∆ogt. I speculate that this may be a result of 
structural changes or alternative glycosylation patterns allowing the un-modified 
D-loop to revert back to wild type function.  
Notably, other mutant phenotypes are not rescued by the PilA mutation, 
possibly due to effects of the pilA-like gene distal to the promoter region. 
However, this tandem arrangement of pilA-like genes has been noted as a 
common occurrence, and the distal gene has been shown to be inactive (66). 
The lack of suppression of the inorganic phosphate mutant phenotype may 
indicate that SeOGT acts in several distinct cellular roles. 
Although pili have not been established to have the O-GlcNAc 
modification specifically, they have been reported to carry a variety of 
glycosylations including O-linked moieties (74). We have detected both N- and 
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O-linked modifications on S. elongatus pili, both in wild type and the suppressor 
strain (Fig. 7), but have not determined the nature of the sugar modification. β-
elimination of pili, which removes O-linked glycans, reveals that the ratio of N- 
and O-linkages is altered in the suppressor strain, suggesting a defect in 
regulation. Radioactive labeling of terminal O-GlcNAc results in visible bands, 
and β-elimination of O-linked glycans results in loss of bands, indicating terminal 
O-GlcNAc on pili (Fig.8). Further investigation into the type of glycosylation on S. 
elongatus pili will require structural characterization of the glycans on pili, and 
determination of the glycan positions on the protein.  
 
MATERIALS AND METHODS 
Bacterial Growth.  
Cultures were grown in BG-11 media with no antibiotics unless specified . 
Cultures were grown at 22°C under continuous fluorescent light (33.75 µmol 
photons m-2s-1) with aeration. To aerate, an aquarium air pump (Petco) was used 
to introduce bubbles to the bottom of culture flasks through a Pasteur pipette 
plugged with sterile cotton. 
Genomic DNA Preparation. 
Genomic DNA was extracted using a method based on Clerico et al. (59). 20 mL 
of stationary phase culture was pelleted and left at -80°C overnight. The pellet 
was resuspended in 500 mL 120 mM NaCl and 20 mM EDTA then pelleted and 
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resuspend in 340 mL 25% sucrose 50mM Tris-HCl (pH 8), 10mM EDTA. 2 
mg/mL lysozyme was added and the solution was incubated for 45 minutes at 
37°C. 2 µL 10 mg/mL proteinase K and 20 µL 20% sarkosyl were added and the 
mixture vortexed for 20 seconds and allowed to incubate for 30 minutes at 55°C. 
57 µL 5M NaCl and 45 µL of CTAB were added and the mixture was incubated at 
65°C for 10 minutes. DNA was extracted using 500uL 24:1 chloroform:isoamyl 
alcohol by vortexing and centrifuging at 16,000g in a Beckman JA 18.1 rotor at 
4°C for 10 minutes. The upper phase was transferred to a new tube and 500 µL 
phenol was added, then the mixture was vortexed for 20 seconds. This step was 
repeated once. The upper phase was transferred to a new tube and 2 volumes of 
100% ethanol were added. The DNA was spooled onto a glass Pasteur pipette, 
washed with 70% ethanol, then transferred to a new tube, pelleted, and allowed 
to dry. The pellet was resuspended in 50 µL water. 
Whole Genome Sequencing. 
All sequencing was completed at the University of Minnesota Genomics Center 
using the Illumina Paired-end MiSeq platform (250bp paired-end, insert size = 
280bp). Libraries were created for wild type (Adaptor #2 – CGATGT), mutant 1 
(Adaptor #7 – CAGATC), mutant 2 (Adaptor #16 – CCGTCC), and the null 
mutant (Adaptor #4 – TGACCA) using the Illumina TruSeq DNA Sample 
Preparation Kit. All raw sequencing files have been submitted to NCBI Sequence 
Read Archive under accession number PRNJA268360 SRPXXXXX. FASTQ files 
from all sequencing runs were imported into CLC Genomics Workbench Version 
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6.5 (CLC Bio, www.clcbio.com) and analyzed on the desktop computer described 
in Dorn et al. (75). Illumina reads were subjected to quality control using the 
Sequencing QC Report tool. 250 bp paired-end Illumina reads were trimmed and 
filtered using the following parameters: Ambiguous Trim = Yes, Ambiguous Limit 
= 2, Quality Limit = 0.05, Use Colorspace = No, Search Reverse Sequence = 
Yes, Remove 5’ terminal nucleotides = Yes, Number of 5’ Terminal Nucleotides 
to Remove = 10, Remove 3’ terminal nucleotides = No, Discard Long Reads = 
No, Save Broken Pairs = No. Trimmed and filtered reads were mapped to the 
Synechococcus elongatus genome (GenBank accession NC_007604) and 
plasmid (GenBank accession CP000101) using the ‘Map Reads to Reference’ 
tool in CLC Genomics Workbench (Mapping Parameters: Masking mode: No 
Masking, Mismatch cost = 3, Insertion cost = 3, Deletion cost = 3, Length 
Fraction = 0.95, Similarity Fraction = 0.95, Global Alignment = No, Auto-detect 
paired distances = Yes, Non-specific match handling = Ignore). Sequence 
variants were analyzed using the ‘Probablistic Variant Detection’ tool in CLC 
Genomics Workbench (Parameters: Ignore non-specific matches = Yes, Ignore 
Broken Pairs = Yes, Minimum Coverage = 10, Variant Probability = 0.90, 
Required Variant Count = 2, Require presence of both forward and reverse reads 
= Yes, Ignore variants in non-specific regions = No, Maximum Expected Variants 
= 2). Bioproject information: Bioproject PRJNA268360, Wild type SRR Accession 
# SRR1685987, deletion mutant (null ogt) SRR Accession # SRR1686015, 
Suppressor mutant SRR Accession # SRR1686063. 
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Congo Red assay for pili. 
To determine pilin abundance, a Congo Red assay was adapted from Black and 
Yang (76). Cells were grown to exponential phase, then 1 mL was gently 
pelleted, and resuspended in 500 µL Congo Red buffer (10 mM Tris (pH 7.5), 1 
mM KH2PO4, 5 mM MgSO4, and 15 µg/mL Congo Red). Cells were incubated at 
25°C for 30 minutes in a dark room. Cells were then pelleted and supernatant 
was transferred to cuvettes. Absorbance at 490 nm was measured. Cell free 
samples were used as controls. 
TEM. 
TEM images were obtained using a modified protocol from Ahlawat et al. (77). 
Briefly, a 400 mesh copper grid was layered with formvar and carbon film. Grids 
were put into 10 µl poly-L-lysine, which was then blotted off. Cells were applied to 
the grid upside down using 6 µl of saturated culture, 2 µl glutaraldehyde and 2 µl 
sodium phosphate buffer for 20 minutes. Slightly dried grids were stained with 
uranyl formate. Cells were visualized using a Philips CM12 Transmission 
Electron Microscope and digitally photographed. 
Inorganic phosphate measurements.  
S.elongatus cultures were grown to exponential phase and cells were pelleted by 
centrifugation for 15 minutes at 3700xg in a JA-20 rotor (Beckman). The cell 
pellets were frozen at -80°C, thawed, and re-suspended in French Press Buffer 
consisting of 20 mM Tris-HCl (pH 7.5), 2 mM EDTA, 1 M sodium perchlorate, 1% 
SDS w/v  and cells were disrupted via two passes through a French Press. 
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Cellular debris was cleared by centrifugation at 4°C for 15 minutes, at 20,000xg 
in a JA-20 rotor (Beckman) and aliquots of the supernatant were frozen at -20°C.  
 Free inorganic phosphate was determined using a modified protocol from 
Werner et al. (46). 50 µL of cell lysate was added to 50 µL 1M sulfuric acid and 
vortexed briefly. The mixture was incubated for five minutes, then neutralized 
with 50 µL 2M sodium hydroxide and 100 µL Red Tris solution (1M Tris-HCl (pH 
7.5), 6% Neutral Red solution (Ricca Chemical Company, Arlington TX)), 
vortexed, then centrifuged to remove precipitated proteins. pH was assessed via 
color test and adjusted to neutral (acidic solutions are pink, basic solutions are 
yellow and neutral pH solutions are pinkish-orange). 50 µL aliquots of this 
neutralized solution were transferred to microcentrifuge tubes.  
 To measure phosphate in these samples, 344 µL of 28mM ammonium 
heptamolybdate in 2.1M sulfuric acid was added to each tube and tubes were 
incubated for 20 minutes at 22°C. To develop color, 256  µL of 0.76mM malachite 
green oxalate in 0.35% polyvinyl alcohol was added to each sample and 
incubated for 20 minutes at 22°C. Absorbance at 595 nm was then measured. A 
standard curve using fresh potassium phosphate solutions was created for each 
experiment.  
Isolation of pili. 
Cultures were grown to saturation and 300 mLs were centrifuged at 4000xg in a 
JA-10 rotor (Beckman) for 20 minutes. The pellet was resuspended in 5 mL 5 
mM Tris (pH 8.0). Samples were sheared for 3 minutes using a polytron 
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(Kinematica) at level 4, then centrifuged at 12,000xg for 30 minutes in a JA-20 
rotor (Beckman). Supernatant was collected, and ammonium sulfate was added 
to 50%. The solution was stirred overnight at 4°C, then centrifuged at 12,000xg 
for 60 minutes in a JA-20 rotor. The pellet was resuspended in 300 µL 5mM Tris-
HCl (pH 7.5) and dialyzed against 1 L 5 mM Tris-HCl (pH 7.5). 
Transgene complementation. 
Transgenes were produced using the pSyn vector (Invitrogen) according to 
manufacturer’s protocols. Briefly, genes and putative promoter regions were PCR 
amplified and cloned into the pSyn_1/D-TOPO vector. Strains were transformed 
as previously described (Sokol & Olszewski 2015), and transformants selected 
using spectinomycin resistance. Primer pairs included in the pSyn kit were used 
to verify strain transformation. 
BEMAB. 
Samples were run on 15% SDS-PAGE gels and transferred to PVDF membrane. 
In a technique adapted from Wells et al (2002), the blot was incubated in 5 mL of 
1% triethylamine, 0.1% NaOH, 3 mM biotin-PEG3-amine (ChemPep). The blot 
was then incubated at 37°C for 24 hours with gentle agitation. The blot was 
washing with ddH20, blocked in PBS with 0.05% Tween and 3% BSA, and 
probed with Streptavidin-HRP, which was detected by chemiluminescence. 
GalT on the blot labeling. 
Samples were run on 15% SDS-PAGE gels and transferred to PVDF membrane. 
Membrane was blocked overnight at 4°C in 3% bovine serum albumin in 10 mM 
 81 
HEPES (pH 7.9).  Membrane was washed in 10 mM HEPES (pH 7.9) for 10 
minutes with gentle shaking. Three µCi of UDP-H3-Galactose was dried under 
argon and resuspended in 3 µL 25 mM AMP and added to 800 µL labeling buffer 
(10 mM HEPES (pH 7.9), 1M MNCl2, 1% BSA, protease inhibitor, and 100m units 
calf intestinal phosphatase. The membrane was sealed in plastic and incubated 
for 3 hours at 37°C. The membrane was washed 7 times for 10 minutes each in 
10 mM HEPES pH (7.9). The membrane was dried and sprayed with EN3HANCE 
(PerkinElmer) and dried for 20 minutes. The membrane was placed on pre-
flashed film, then sealed and placed at -80°C for 72 hours. 
Glycodetection. 
Proteins in pili preparations were resolved by PAGE on a 15% gel and 
transferred to a PVDF membrane.  The membrane was wet with 95% ethanol, 
rinsed in H2O and washed 3x in 100 mM sodium acetate (pH 5.5) for 5 minutes. 
Glycoproteins on the membrane were oxidized by incubating the membrane in 50 
mL of freshly prepared 100 mM sodium acetate (pH 5.5) containing 20 mM 
sodium periodate at room temperature in the dark for 30 minutes. The membrane 
was washed for 5 minutes in 50 mL of 20 mM sodium phosphate (pH7.4) 
containing 20 mM sodium sulfite and then washed three additional times in 
20mM sodium phosphate (pH7.4). After transferring the membrane to a seal-a-
meal bag, the glycoproteins were biotinylated by adding 8 mL of 20 mM sodium 
phosphate (pH 7.4) to which 400µL of DMSO in which 10.4 mg of biotin 
hydrazide had been dissolved. The biotinylation reaction was performed at room 
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temperature for 2 hours. The reaction was terminated by washing the membrane 
3 times for 5 minutes in PBS. Biotin on the membrane was detected using 
strepavidin-HRP. 
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Figure 1. Suppression of ∆ogt phenotypes. (A) The suppressor strain is rescued 
for the ogt mutant settling phenotype. (B) The suppressor strain has similar 
percentage of cells in aggregates as wild type, indicating the suppressor 
mutation also suppressed the aggregation phenotype. Aggregates of two or more 
cells were counted, excluding cells with end-to-end aggregates, as these may be 
dividing cells. Bars in A and B indicate standard error, some bars being too small 
to be visible. In B, analysis of variance (ANOVA) was performed. Asterisk 
indicates significant difference (p < 0.05).  
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Figure 2. Non-suppression of ∆ogt phosphate phenotype. ∆ogt cells have higher 
inorganic phosphate than wild type cells, and the suppressor mutation does not 
rescue this mutant phenotype. Inorganic phosphate is expressed as phosphate 
per mg of protein in cell lysates. Bars indicate standard error. ANOVA was 
performed. Asterisks indicate significant difference from wild type (P < 0.05). 
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Figure 3. Diagram of missense mutation in PilA. (A) Nucleotide sequence of PilA 
(top line) and the suppressor mutation (bottom line). (B). Amino acid sequence of 
PilA (top line), consensus sequence (middle line) and the pilA suppressor 
mutation which causes an alanine to aspartic acid change (A107D). The 
predicted D-loop region adjacent to the mutation is noted. 
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Figure 4. Suppression of ∆ogt loss of pili phenotype. (A) Congo Red 
preferentially binds to pili. Cells with fewer pili bind less Congo Red dye 
suggesting a loss of pili in ∆ogt cells which is then restored in ∆ogt,pilA(A107D). 
Bars indicate standard error. ANOVA was performed. Asterisks indicate 
significant difference from wild type (P < 0.05). (B) TEM imaging of negatively 
stained cells reveals a loss of pili in the ∆ogt mutant, but reversion to wild type in 
the suppression mutant ∆ogt, pilA(A107D).  
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Figure 5. Transgene effects on pili and settling phenotypes. Several transgene 
experiments were performed. OGT and pilA transgenes were separately 
introduced to the Neutral Site I of ∆ogt, pilA(A107D). Wild type was transformed with 
pilA(A107D.). A) Congo Red was used to determine the presence of pili. Bars 
indicate standard error. ANOVA was performed. Asterisks indicate significant 
difference from wild type (P < 0.05).  B) The settling phenotype was determined 
for each of the transgene constructs. Bars indicate standard error, with some 
bars too small to be visible. 
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 Figure 6. BEMAB treatment. Twenty µg of isolated pili were run on an SDS 
PAGE gel and transferred to a PVDF membrane. β-elimination of O-linked 
glycans was performed, followed by Michael addition of biotin. Biotin was 
detected using streptavidin-HRP. Both wild type and ∆ogt,pilA(A107D) show pili with 
O-linked glycans. ∆ogt shows inhibited pili formation. 
  
 94 
 
  
(A017D) 
 95 
Figure 7. Glycosylation of pili. A) Glycodetection on bands running at the 
predicted size for pili reveal glycosylation on both wild type and ∆ogt,pilA(A107). B) 
After elimination of O-linked glycans, glycosylation ratios change in both strains. 
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Figure 8. Detection of terminal O-linked GlcNAc. Isolated pili were run on a 15% 
SDS-PAGE gel and transferred to PVDF membrane. Glycans terminating with O-
GlcNAc were labeled with H3-Galactose A) Both WT and ∆ogt,pilA(A107D) show 
bands of terminal O-GlcNAc near the predicted size of pili. B) β-elimination of O-
linkages removes both of these bands, suggesting that both have structures with 
a terminal GlcNAc. 
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Chapter Four 
Conclusions and Future Directions 
 The eukaryote-like O-GlcNAc transferase of Synechococcus elongatus 
PCC7942 hydrolyzes the UDP-GlcNAc sugar donor and has a role in settling, 
aggregation, and inorganic phosphate levels. These phenotypes, of which only 
settling and aggregation are affected by the suppressor mutation, indicate that 
some of these cellular processes may be independent. Glycosylation status of pili 
may affect pili formation, via the PilA subunit. Of particular interest in these 
phenotypes are the loss of motility, loss of pili, and the increased cellular 
inorganic phosphate.  
Despite the suggestion of multiple cellular roles for SeOGT, the 
mechanisms by which SeOGT affects these cellular processes remain unclear. 
To date, no O-GlcNAcylated proteins have been identified in Synechococcus 
elongatus PCC7942. Ultimately, identification of the substrates of the OGT would 
aid in elucidation of the cellular roles of the enzyme, and allow for S. elongatus to 
serve as a model system for studying the O-GlcNAc modification. To that end, 
several avenues of study are apparent. 
 Metazoan O-GlcNAcylation acts in both the nucleus and cytosol on varied 
systems. The location of the OGT in the bacteria may elucidate which cell 
fractions to investigate for SeOGT substrate proteins. For instance, loss of 
SeOGT leads to loss of pili on the exterior of the cell. A significant amount of 
bacterial glycosylation occurs in the periplasm. If SeOGT is found in the 
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periplasm or near the inner membrane, we can extrapolate that it may be acting 
on a protein involved in the pilus assembly mechanism. Similarly, if SeOGT is 
found near the genomic DNA, it may be acting on transcription factors. To 
determine the location of SeOGT, immunolabeling could be used in immunogold 
staining and imaged in sections on a transmission electron microscope. To this 
end, I have created a strain with an epitope tagged fusion protein of SeOGT 
tagged with 3xFLAG tag (Fig. 1) in the null OGT background strain, which could 
be used towards this goal. The FLAG tag can be visualized using a primary 
antibody and a secondary antibody fused with colloidal gold particles, then 
examined under transmission electron microscopy. 
 To further investigate the cellular roles of O-GlcNAcylation in bacteria, 
mutant phenotypes of the ∆ogt strain remain to be investigated. Of particular 
interest are the high inorganic phosphate found in mutant cells and loss of pili. 
Because the regulation of phosphate acquisition, storage, and release are well-
studied, there are many targets for study in this pathway, including the PhoB-
PhoR transcriptional regulators, the pst system which transports inorganic 
phosphate across the cytoplasmic membrane, and ppK and ppX which serve as 
a phosphate kinase and an exopolyphosphatase respectively and control storage 
and use of inorganic phosphate. The Pho regulon, which is responsible for 
phosphate regulation, is conserved in Synechococcus elongatus. Investigation 
into expression of the genes in this regulon could elucidate irregularities in 
genetic regulation. Co-expression studies in E. coli using SeOGT and some of 
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the key phosphate regulation proteins may uncover an O-GlcNAcylation 
substrate in the phosphate regulon. Genes involved in pili production are also 
well characterized. Deletion mutants in both wild type and ∆ogt may help 
elucidate the step in pili production in which O-GlcNAcylation is involved. 
 Similar to the discovery of the spontaneous suppressor, the settling 
phenotype of ∆ogt could be used in further suppressor screening, analyzing 
those strains that regain the ability to remain in culture. This approach could 
uncover additional genes involved in O-GlcNAcylation-dependent motility. 
Although more time-consuming, other phenotypes could also be used in a 
suppressor screen, including aggregation and inorganic phosphate levels to 
determine the role(s) of O-GlcNAcylation in these phenotypes. 
The loss of pili in the ∆ogt mutant, along with the suppressor mutation in 
pilA, is compelling evidence that SeOGT is acting on the assembly or stability of 
pili. Antibodies raised against PilA would serve several purposes in the 
investigation of this mutant phenotype. The presence of the mutant protein 
despite the lack of pili would suggest that assembly defects are present, whereas 
its absence would suggest instability of the translated protein, aberrant 
localization, or instability of PilA when not incorporated into pili. In the absence of 
protein, knowledge of transcription rates of pilA could help determine if the gene 
is being down regulated. Co-localization studies of SeOGT using the previously 
described SeOGT-FLAG construct and PilA antibodies would be helpful in 
ascertaining whether SeOGT works directly on the assembly machinery of pili. 
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The location of the mutation in the mutant PilA raises interesting 
questions. Proximity to the putative disulfide bond creating the D-loop may 
suggest that mutant subunits are unable to assemble. Directed mutagenesis of 
amino acid residues in this region could lead to a better understanding of the 
relationship and interactions of the PilA subunits. 
 When mutant pilA is introduced to wild type cells, there is a loss of motility 
and a decrease in pili, suggesting that wild type PilA and PilA(A107D) may not be 
able to polymerize into full length pili. This may be due to altered glycosylation 
patterns in PilA(A107D)  affecting polymerization, or conversely, it may be the effect 
of defects in the assembly machinery when PilA(A107D) is present.  Although O-
GlcNAcylation of pili has not been demonstrated, differential glycosylation 
patterns on wild type and suppressor pili are apparent. Further study into the 
modifications of pili using mass spectrometry may give insight into the functional 
importance of pili glycosylation, including glycan structure and location of 
glycans. This information may also give insight into whether glycosylation 
patterns are involved in PilA-PilA subunit interactions. 
 As noted in Chapter Two, a more holistic approach may be required to 
identify SeOGT substrates in Synechococcus elongatus. Glycoproteomics, using 
mass spectrometry, would be useful to uncover a spectrum of O-GlcNAcylated 
proteins. Additionally, several techniques have been reported to map the sites of 
O-GlcNAcylation on peptides. Once peptide substrates are identified, the site(s) 
of modification can be uncovered using techniques such as electrospray 
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ionization-collision induced dissociation tandem mass spectrometry (ESI-CID-
MS/MS).  
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Figure 1. Map of SeOGT-Flag fusion construct. 
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Appendix I - Toxicity of SeOGT in E.coli 
 
There is anecdotal evidence of toxicity of SPY-like OGTs in E.coli cloning strains, 
but no documented evidence (Olszewski, personal comm.). Upon multiple 
cloning attempts of SeOGT, very few transformants were observed in several 
E.coli cell lines. Additionally, numerous colonies contained plasmids with mutated 
or shuffled SeOGT constructs, which presumably resulted in inactive SeOGT. 
E.coli does not have any SPY-like OGT homologs. To investigate the possibility 
that SeOGT is toxic to E.coli, Rebeccca Choi, an undergraduate assistant from 
Macalaster College (St.Paul, MN) undertook several experiments to determine 
whether introduction of mutant SeOGT into E.coli results in more transformants 
than wild type SeOGT. 
 
The Gateway plasmid pDONR SeOGT described in Chapter Two, including the 
SeOGT plus 500bp upstream to include native promoter, was used for wild type 
transformations. The previously described “active site lid” mutant corresponding 
to the spy12 mutation SeOGT, G350D, was used for mutant transformations. 
Electro-competent E. coli strains DH5α and MC1061 were electroporated using 
400ng DNA, and dilutions were plated (10-1 to 10-4) on selective media. Following 
an overnight incubation at 37°C, colonies were counted on appropriate dilution 
plates to determine Colony Forming Units per milliliter of electroporation 
(CFUs/mL). Restriction digests were performed using PvuII enzyme (NEB) on 
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two wild type and two mutant transformants to determine whether the resulting 
plasmids had altered sequences. 
 
 DH5α MC1061 
WT SeOGT 40  9.9x105 
G350D mutant 60 >1x107 
 
Table A1.  Colony Forming Units per milliliter of electroporated culture are over 
10,000 fold lower for wild type SeOGT compared to mutant SeOGT in MC1061, 
and slightly lower in DH5α, which shows significantly fewer overall transformants. 
 
Wild type SeOGT with native promoter results in over 10,000 fold fewer 
transformants after electroporation. Additionally, genetic shuffling was observed 
in both of the wild type transformants (data not shown), resulting in mutant 
SeOGT genes within the vector. These results support previous observations 
that a wild type SPY-like OGT decreases transformation efficiency and results in 
shuffled gene sequences. Although cultures with intact SeOGT sequence can be 
recovered and maintained for cloning purposes, it appears that SeOGT is toxic to 
E. coli. The mechanism for this toxicity remains unknown, as E. coli does not 
have a native OGT, and therefore, most likely does not have native substrates. 
Because SeOGT has been shown to have hydrolytic activity against the UDP-
GlcNAc sugar donor, and the G350D mutation decreases this activity (28), wild 
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type enzyme may be hydrolyzing the native UDP-GlcNAc pool. Because bacterial 
cell surfaces are sites of high concentration of glycolipids containing GlcNAc 
moieties, the depletion of the UDP-GlcNAc sugar donor pool may be affecting 
cell walls and decreasing viability. 
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Appendix II - Other experiments 
Glycostaining of cellular proteins 
100 µL of high density cultures was centrifuged and resuspended in 1 mL PBS. 
Cultures were sonicated on ice (1 second on, 4 seconds off for 25 pulses). 
Proteins from soluble, insoluble, and thylakoid fractions of wild type, ∆ogt, and 
∆ogt, SeOGT were run on 12% SDS-PAGE gels, one of which was Coomassie 
stained and the other subject to glycostaining. Glycostaining was performed 
according to manufacturer’s protocol for Pro-Q Emerald 488 Glycoprotein Gel 
and Blot Stain Kit (Molecular Probes). No differences in protein glycosylation 
were detected between any of the genotypes. 
 
Xanthomonas campestris OGT does not rescue ∆ogt 
The OGT from Xanthomonas campestris has been crystallized and shows 
homology to the human OGT as well as the SeOGT(see Chapter One for 
review). XcOGT was cloned and introduced into the ∆ogt strain using previously 
described methods (Chapter Two). Transformants were genotyped and tested for 
rescue of the settling phenotype. No rescue was observed. 
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Appendix III - List of Strains Created 
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